GMO offers institutionally-oriented global investment strategies.
For client inquiries, please contact your Client Relationship
Manager. For new business inquiries, please contact your Relationship Manager or Holly Carson at (617) 346-7501 or holly.carson@gmo.com This is not an offer or solicitation for the purchase or sale of any security and should not be construed as such. GMO Capabilities * Certain GMO capabilities are not available through separately managed accounts and therefore information on those capabilities are not included in this document. For information please contact GMO. GMO Multi-Asset Class Page Benchmark-Free Allocation 4 Global Allocation Absolute Return 6 Global Asset Allocation 8 Real Return Global Balanced Asset Allocation 10 Tax-Managed Global Balanced 12 GMO Global Equities Page Global All Country Equity Allocation 14 Global Developed Equity Allocation 16 Global Focused Equity 18 Quality 20 Resources 22 GMO International Equities Page International All Country Equity Allocation 24 International Developed Equity Allocation 26 Tax-Managed International Equities* International Equity 28 International Active EAFE 30 International Active Foreign Small Companies 32 International Small Companies* GMO U.S. Equities Page U.S. Equity Allocation 34 GMO Emerging Equities Page Emerging Markets 36 1 Emerging Countries* Emerging Domestic Opportunities 38 GMO Fixed Income Page Global Bond 40 International Bond 42 Currency Hedged International Bond 44 Core Plus Bond 46 Emerging Country Debt* Emerging Country Local Debt* Debt Opportunities 48 GMO Absolute Return Page Emerging Country Debt Long/Short* Fixed Income Hedge 50 Mean Reversion 52 Systematic Global Macro 54 Tactical Opportunities 56 Total Equities 58 Multi-Strategy* 1 2014 Performance of GMO Strategies and Benchmarks Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. Copyright 2014 by GMO. All rights reserved. This document may not be reproduced, distributed or transmitted, in whole or in portion, by any means, without written permission from GMO. Total Return Net of Fees Average Annual Total Return GMO Multi-Asset Class Inception 2Q YTD YTD Value One Five Ten Since Strategies/Benchmarks Date 2014 2014 Added Year Year Year Inception Benchmark-Free Allocation 7/31/01 3.43 4.69 3.36 11.83 9.39 9.33 11.28 CPI 0.87 1.33 2.04 2.08 2.30 2.29 Global Allocation Absolute Return 7/31/01 3.22 4.42 3.10 10.97 8.28 8.39 9.85 CPI 0.87 1.33 2.04 2.08 2.30 2.29 Global Asset Allocation 6/30/88 3.70 5.47 0.02 14.81 10.86 7.59 9.96 Blended Benchmark 3.99 5.45 16.25 11.23 6.40 8.31 Real Return Global Balanced Asset Alloc. 6/30/04 3.26 5.25 0.72 13.91 9.79 7.62 7.62 Blended Benchmark 3.31 4.53 14.96 10.08 5.95 5.95 Tax-Managed Global Balanced 12/31/02 2.92 4.61 -0.85 13.40 8.92 6.90 8.12 GMO Tax-Managed Global Balanced Index 3.89 5.46 15.71 10.93 6.33 7.48 GMO Global Equities Inception 2Q YTD YTD Value One Five Ten Since Strategies/Benchmarks Date 2014 2014 Added Year Year Year Inception Global All Country Equity Allocation 12/31/93 4.91 7.06 0.87 22.57 14.13 8.79 9.58 Blended Benchmark 5.04 6.19 23.10 14.62 7.35 7.73 Global Developed Equity Allocation 3/31/87 4.79 7.58 1.40 24.57 14.87 8.44 9.79 Blended Benchmark 4.86 6.18 24.05 15.00 7.13 7.64 Global Focused Equity 12/31/11 5.38 6.15 -0.03 32.21 N/A N/A 22.72 MSCI ACWI 5.04 6.18 22.95 N/A N/A 18.05 Quality 2/29/04 3.69 5.77 -1.36 17.59 15.85 6.89 6.71 S&P 500 5.23 7.14 24.61 18.83 7.78 7.54 Resources 12/31/11 10.58 11.86 2.47 29.14 N/A N/A 10.22 MSCI ACWI Commodity Producers 9.28 9.39 24.97 N/A N/A 5.83 GMO International Equities Inception 2Q YTD YTD Value One Five Ten Since Strategies/Benchmarks Date 2014 2014 Added Year Year Year Inception International All Country Equity Alloc. 2/28/94 5.91 7.89 2.35 26.40 12.16 8.72 8.20 Blended Benchmark 5.01 5.54 21.78 11.07 7.69 6.17 International Developed Equity Allocation 11/30/91 5.54 9.02 4.24 30.16 13.28 8.31 8.96 Blended Benchmark 4.09 4.78 23.57 11.82 7.20 6.79 International Equity 3/31/87 5.22 8.73 2.72 32.01 11.75 7.07 8.62 MSCI EAFE + 4.73 6.01 26.86 11.24 6.71 7.48 MSCI EAFE 4.09 4.78 23.57 11.77 6.93 6.18 International Active EAFE 5/31/81 2.99 1.93 -2.85 21.97 10.39 6.34 12.15 MSCI EAFE 4.09 4.78 23.57 11.77 6.93 9.32 Int'l. Active Foreign Small Companies 1/31/95 1.90 5.02 -2.22 25.85 17.31 11.13 11.94 S&P Developed ex-U.S. Small Cap 3.40 7.24 29.95 15.47 9.64 7.90 GMO U.S. Equities Inception 2Q YTD YTD Value One Five Ten Since Strategies/Benchmarks Date 2014 2014 Added Year Year Year Inception U.S. Equity Allocation 2/28/89 3.34 5.53 -1.60 18.05 16.46 6.90 10.83 Blended Benchmark 5.23 7.14 24.86 19.15 8.05 10.36 2 2014 Performance of GMO Strategies and Benchmarks Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. * Returns for one of the accounts in the composite are based on estimated market values for the period from and including October 2008 through February 2009. Total Return Net of Fees Average Annual Total Return GMO Emerging Equities Inception 2Q YTD YTD Value One Five Ten Since Strategies/Benchmarks Date 2014 2014 Added Year Year Year Inception Emerging Markets 12/31/93 8.13 4.95 -1.87 13.39 8.51 11.07 8.05 S&P/IFCI Composite 7.51 6.82 16.00 10.14 12.91 6.28 MSCI Emerging Markets 6.60 6.14 14.31 9.24 11.94 5.66 Emerging Domestic Opportunities 3/31/11 5.60 2.94 -3.20 5.56 N/A N/A 6.01 MSCI Emerging Markets 6.60 6.14 14.31 N/A N/A -0.71 GMO Fixed Income Inception 2Q YTD YTD Value One Five Ten Since Strategies/Benchmarks Date 2014 2014 Added Year Year Year Inception Global Bond* 12/31/95 3.07 7.33 2.28 8.97 9.22 5.20 6.04 J.P. Morgan GBI Global 2.28 5.05 6.50 3.80 4.96 5.24 International Bond 12/31/93 3.43 8.80 2.73 12.88 9.91 5.92 7.23 J.P. Morgan GBI Global ex U.S. 2.68 6.07 8.92 3.80 5.06 5.72 Currency Hedged Int'l. Bond 9/30/94 3.00 8.03 1.91 8.81 9.88 5.37 7.98 J.P. Morgan GBI Global 2.62 6.12 7.56 5.46 5.38 6.91 ex-Japan ex U.S. (Hedged) + Core Plus Bond 4/30/97 2.59 5.74 1.81 6.44 9.90 5.06 6.10 Barclays U.S. Aggregate 2.04 3.93 4.37 4.85 4.93 5.81 Debt Opportunities 10/31/11 1.70 3.19 3.02 6.08 N/A N/A 7.84 J.P. Morgan U.S. 3 Month Cash 0.08 0.17 0.36 N/A N/A 0.57 GMO Absolute Return Inception 2Q YTD YTD Value One Five Ten Since Strategies/Benchmarks Date 2014 2014 Added Year Year Year Inception Fixed Income Hedge 8/31/05 1.40 5.99 5.81 2.51 8.96 N/A -0.34 J.P. Morgan U.S. 3 Month Cash 0.08 0.17 0.36 0.53 N/A 2.26 Mean Reversion 2/28/02 -0.84 0.06 0.04 -4.29 0.30 4.49 7.17 Citigroup 3-Mo. T-Bill 0.01 0.02 0.04 0.08 1.54 1.49 Systematic Global Macro 3/31/02 -0.67 1.41 1.39 4.79 7.11 6.71 7.34 Citigroup 3-Mo. T-Bill 0.01 0.02 0.04 0.08 1.54 1.49 Tactical Opportunities 9/30/04 -5.01 -7.51 -7.53 -14.93 -12.25 N/A -7.22 Citigroup 3-Mo. T-Bill 0.01 0.02 0.04 0.08 N/A 1.55 Total Equities 9/30/00 2.53 3.68 3.66 17.12 6.87 3.54 6.59 Citigroup 3-Mo. T-Bill 0.01 0.02 0.04 0.08 1.54 1.77 3 As of June 30, 2014 GMO 2014 GMO Benchmark-Free Allocation Strategy Inception: 7/31/01; Benchmark: Consumer Price Index 1 Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. The chart above shows the past performance of the Benchmark-Free Allocation Composite (the Composite). Prior to January 1, 2012, the accounts in the Composite served as the principal component of a broader real return strategy. Beginning January 1, 2012, accounts in the composite have been managed as a standalone investment. 2 The CPI (Consumer Price Index) for All Urban Consumers U.S. All Items is published monthly by the U.S. government as an indicator of changes in price levels (or inflation) paid by urban consumers for a representative basket of goods and services. 3 The groups indicated above represent exposures determined pursuant to proprietary methodologies and are subject to change over time. 4 The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the Strategy. 5 Std. Deviation is a measure of the volatility of a portfolios return. Sharpe Ratio is the return over the risk free rate per unit of risk. Drawdown is the largest negative cumulative portfolio return from peak to trough. Risk profile data is net. Performance Net of Fees 1
5-Year Risk Profile 5
Bond Portfolio 4
Equity Regional Weights (%) 4 Group Exposures (%) 3,4
Equity Characteristics 4
Other Equity Absolute Return Cash U.S. Equity Intl. Developed Equity Emerging Equity Fixed Income St r at egy Price/Earnings - Hist 1 Yr Wtd Med 15.5 x Price/Book - Hist 1 Yr Wtd Avg 1.6 x Return on Equity - Hist 1 Yr Med 11.1 % Market Cap - Weighted Median $Bil $40.1 Dividend Yield - Hist 1 Yr Wtd Avg 3.1 % 20.8 27.8 7.5 1.5 8.2 34.3 0 10 20 30 40 Emerging Europe ex UK J apan Other International United Kingdom United States Strategy Bond Portfolio Duration 5.6 years Credit Ratings AAA 3.3% BB 10.5% AA 40.5% B 6.4% A 5.8% <B 12.0% BBB 20.2% NR 1.4% St r at egy Std. Deviation 6.21 Sharpe Ratio 1.50 Drawdown (4/30/10-6/30/10) -5.91 0 20 40 60 80 100 U.S. Quality, 10.7 Europe Value, 14.5 Other Int'l. Opportunistic Value, 0.8 Emerging Markets, 8.4 Cash & Cash Equiv., 19.5 Debt Opportunities, 5.0 Risk Premium, 3.9 J apan, 3.0 U.S. Opportunistic Value, 3.3 Alpha Only, 15.9 TIPS, 5.0 Emerging Country Debt, 3.5 Systematic Global Macro Opportunity, 6.5 Tot al Ret ur n (%) Aver age Annual Tot al Retur n (%) 2Q YTD One Five Ten Since 2014 2014 Year Year Year Inception Strategy 3.43 4.69 11.83 9.39 9.33 11.28 Benchmark 2 0.87 1.33 2.04 2.08 2.30 2.29 Annual Tot al Retur n (%) 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Strategy 17.96 16.32 12.75 10.93 -12.07 19.86 4.58 3.60 10.35 11.24 Benchmark 3.35 3.45 2.58 4.12 0.16 2.86 1.25 2.95 1.87 1.56 4 As of June 30, 2014 GMO 2014 Quarterly Strategy Attribution Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. GMO Benchmark-Free Allocation Strategy Inception: 7/31/01; Benchmark: Consumer Price Index 5 As of June 30, 2014 GMO 2014 GMO Global Allocation Absolute Return Strategy Inception: 7/31/01; Benchmark: Consumer Price Index 1 Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. 2 The GMO blended Global Asset Allocation Composite benchmark is comprised of a weighted average of account benchmarks; many of the account benchmarks consist of S&P 500, MSCI ACWI (MSCI Standard Index Series, net of withholding tax) and Barclays Aggregate or some like proxy for each market exposure they have. For each underlying account benchmark, the weighting of each market index will vary slightly. The index is internally blended by GMO and maintained on a monthly basis. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder. 3 The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the Strategy. 4 Std. Deviation is a measure of the volatility of a portfolios return. Sharpe Ratio is the return over the risk free rate per unit of risk. Drawdown is the largest negative cumulative portfolio return from peak to trough. Risk profile data is net. Performance Net of Fees 1
5-Year Risk Profile 5
Bond Portfolio 4
Equity Regional Weights (%) 4 Group Exposures (%) 3,4
Equity Characteristics 4
Other Equity Absolute Return Cash U.S. Equity Intl. Developed Equity Emerging Equity Fixed Income St r at egy Std. Deviation 5.28 Sharpe Ratio 1.55 Drawdown (3/31/10-6/30/10) -4.95 20.6 27.7 7.6 1.6 8.2 34.4 0 10 20 30 40 Emerging Europe ex UK J apan Other International United Kingdom United States Strategy St r at egy Price/Earnings - Hist 1 Yr Wtd Med 15.5 x Price/Book - Hist 1 Yr Wtd Avg 1.6 x Return on Equity - Hist 1 Yr Med 11.0 % Market Cap - Weighted Median $Bil $41.3 Dividend Yield - Hist 1 Yr Wtd Avg 3.2 % Bond Portfolio Duration 2.4 years Credit Ratings AAA 1.4% BB 5.0% AA 72.3% B 3.2% A 2.6% <B 5.3% BBB 9.5% NR 0.7% Tot al Ret ur n (%) Aver age Annual Tot al Retur n (%) 2Q YTD One Five Ten Since 2014 2014 Year Year Year Inception Strategy 3.22 4.42 10.97 8.28 8.39 9.85 Benchmark 2 0.87 1.33 2.04 2.08 2.30 2.29 Annual Tot al Retur n (%) 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Strategy 15.29 13.54 11.01 9.99 -7.19 14.92 3.02 4.22 9.42 10.04 Benchmark 3.35 3.45 2.58 4.12 0.16 2.86 1.25 2.95 1.87 1.56 0 20 40 60 80 100 U.S. Quality, 10.5 Europe Value, 14.4 Other Int'l. Opportunistic Value, 0.8 Emerging Markets, 8.2 Cash & CashEquiv., 3.3 Debt Opportunities, 3.5 Asset AllocationBond, 17.0 Risk Premium, 4.0 J apan, 3.1 U.S. Opportunistic Value, 3.2 Systematic Global Macro Opportunity, 3.2 Alpha Only, 5.0 Emerging Country Debt, 3.4 Multi Strategy, 20.0 Special Situations, 0.4 6 As of June 30, 2014 GMO 2014 Quarterly Strategy Attribution Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. GMO Global Allocation Absolute Return Strategy Inception: 7/31/01; Benchmark: Consumer Price Index 7 As of June 30, 2014 GMO 2014 GMO Global Asset Allocation Strategy Inception: 6/30/88; Benchmark: GMO Global Asset Allocation Index Performance Net of Fees 1
1 Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. 2 The GMO blended Global Asset Allocation Composite benchmark is comprised of a weighted average of account benchmarks; many of the account benchmarks consist of S&P 500, MSCI ACWI (MSCI Standard Index Series, net of withholding tax) and Barclays Aggregate or some like proxy for each market exposure they have. For each underlying account benchmark, the weighting of each market index will vary slightly. The index is internally blended by GMO and maintained on a monthly basis. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder. 3 The groups indicated above represent exposures determined pursuant to proprietary methodologies and are subject to change over time. 4 The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the Strategy. 5 Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R 2 is a measure of how well a portfolio tracks the market; Sharpe Ratio is the return over the risk free rate per unit of risk; Std. Deviation is a measure of the volatility of a portfolio. Risk profile data is net. Performance Net of Fees 1
5-Year Risk Profile 5
Bond Portfolio 4
Equity Regional Weights (%) 4 Group Exposures (%) 3,4
Equity Characteristics 4
Other Equity Absolute Return Cash U.S. Equity Intl. Developed Equity Emerging Equity Fixed Income Tot al Retur n (%) Aver age Annual Total Retur n (%) 2Q YTD One Five Ten Since 2014 2014 Year Year Year Inception Strategy 3.70 5.47 14.81 10.86 7.59 9.96 Benchmark 2 3.99 5.45 16.25 11.23 6.40 8.31 Annual Tot al Retur n (%) 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Strategy 13.55 9.06 12.30 7.94 -20.83 24.15 7.93 2.13 11.11 12.38 Benchmark 10.26 5.99 13.41 9.26 -27.72 24.14 11.05 -1.80 12.13 13.60 St r at egy Benchmar k Alpha 1.45 0.00 Beta 0.84 1.00 R 2 0.95 1.00 Sharpe Ratio 1.31 1.17 Std. Deviation 8.22 9.57 15.8 31.4 8.6 1.8 9.3 33.1 10.9 16.8 7.4 8.3 7.8 48.9 0 20 40 60 Emerging Europe ex UK J apan Other International United Kingdom United States Strategy Benchmark St r at egy Benchmar k Price/Earnings - Hist 1 Yr Wtd Med 15.5 x 18.4 x Price/Book - Hist 1 Yr Wtd Avg 1.6 x 2.1 x Return on Equity - Hist 1 Yr Med 11.0 % 14.3 % Market Cap - Weighted Median $Bil $41.3 $40.0 Dividend Yield - Hist 1 Yr Wtd Avg 3.1 % 2.5 % Bond Portfolio Duration 2.4 years Credit Ratings AAA 1.8% BB 5.6% AA 68.1% B 3.3% A 3.2% <B 6.6% BBB 10.7% NR 0.7% 0 20 40 60 80 100 U.S. Quality, 12.9 Europe Value, 20.9 Other Int'l. Opportunistic Value, 1.2 Emerging Markets, 8.0 Cash & Cash Equiv., 3.8 Debt Opportunities, 4.8 Asset Allocation Bond, 17.0 Risk Premium, 2.5 J apan, 4.4 U.S. Opportunistic Value, 4.0 Alpha Only, 11.2 ABS (Direct), 0.1 Emerging Country Debt, 3.7 Systematic Global Macro Opportunity, 5.0 Special Situations, 0.5 8 As of June 30, 2014 GMO 2014 Quarterly Strategy Attribution Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. GMO Global Asset Allocation Strategy Inception: 6/30/88; Benchmark: GMO Global Asset Allocation Index 9 As of June 30, 2014 GMO 2014 GMO Real Return Global Balanced Asset Allocation Strategy Inception: 6/30/04; Benchmark: Blended Benchmark 1 Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. 2 The GMO blended Real Return Global Balanced Asset Allocation Composite benchmark is comprised of a weighted average of account benchmarks; many of the account benchmarks consist of MSCI World (MSCI Standard Index Series, net of withholding tax), Barclays Aggregate, and Citigroup 3-Month T-Bill or some like proxy for each market exposure they have. For each underlying account benchmark, the weighting of each market index will vary slightly. The index is internally blended by GMO and maintained on a monthly basis. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder. 3 The groups indicated above represent exposures determined pursuant to proprietary methodologies and are subject to change over time. 4 The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the Strategy. 5 Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R 2 is a measure of how well a portfolio tracks the market; Sharpe Ratio is the return over the risk free rate per unit of risk; Std. Deviation is a measure of the volatility of a portfolio. Risk profile data is net. Performance Net of Fees 1
5-Year Risk Profile 5
Bond Portfolio 4
Equity Regional Weights (%) 4 Group Exposures (%) 3,4
Equity Characteristics 4
Tot al Retur n (%) Aver age Annual Total Retur n (%) 2Q YTD One Five Ten Since 2014 2014 Year Year Year Inception Strategy 3.26 5.25 13.91 9.79 7.62 7.62 Benchmark 2 3.31 4.53 14.96 10.08 5.95 5.95 Annual Tot al Retur n (%) 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Strategy 10.11 8.09 13.26 7.63 -11.36 13.02 5.00 3.16 10.65 13.68 Benchmark 7.45 6.82 13.69 7.87 -25.17 19.17 8.94 -1.76 10.42 14.95 St r at egy Benchmar k Alpha 1.87 0.00 Beta 0.78 1.00 R 2 0.90 1.00 Sharpe Ratio 1.33 1.13 Std. Deviation 7.29 8.82 Other Equity Absolute Return Cash U.S. Equity Intl. Developed Equity Emerging Equity Fixed Income 0 20 40 60 80 100 U.S. Quality, 11.9 Europe Value, 19.0 Other Int'l. Opportunistic Value, 1.1 Emerging Markets, 7.3 Cash &Cash Equiv., 1.0 Debt Opportunities, 2.8 Asset Allocation Bond, 15.0 Risk Premium, 2.2 J apan, 4.0 U.S. Opportunistic Value, 3.6 Multi Strategy, 29.0 Emerging Country Debt, 3.1 15.7 31.3 8.6 1.8 9.2 33.4 0.0 18.9 8.3 9.3 8.8 54.8 0 20 40 60 Emerging Europe ex UK J apan Other International United Kingdom United States Strategy Benchmark St r at egy Benchmar k Price/Earnings - Hist 1 Yr Wtd Med 15.5 x 18.7 x Price/Book - Hist 1 Yr Wtd Avg 1.6 x 2.2 x Return on Equity - Hist 1 Yr Med 11.0 % 14.5 % Market Cap - Weighted Median $Bil $42.0 $46.2 Dividend Yield - Hist 1 Yr Wtd Avg 3.1 % 2.4 % Bond Portfolio Duration 2.5 years Credit Ratings AAA 1.3% BB 5.1% AA 73.0% B 3.3% A 2.4% <B 4.9% BBB 9.4% NR 0.7% 10 As of June 30, 2014 GMO 2014 Quarterly Strategy Attribution Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. GMO Real Return Global Balanced Asset Allocation Strategy Inception: 6/30/04; Benchmark: Blended Benchmark 11 As of June 30, 2014 GMO 2014 GMO Tax-Managed Global Balanced Strategy Inception: 12/31/02; Benchmark: GMO Tax-Managed Global Balanced Index 1 Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. 2 The GMO Tax-Managed Global Balanced Index is an internally computed benchmark comprised of (i) 60% MSCI ACWI (All Country World Index) (MSCI standard Index Series, net of withholding tax) and (ii) 40% Barclays Muni 7 Year (6-8) Index. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder. 3 The groups indicated above represent exposures determined pursuant to proprietary methodologies and are subject to change over time. 4 The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the Strategy. 5 Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R 2 is a measure of how well a portfolio tracks the market; Sharpe Ratio is the return over the risk free rate per unit of risk; Std. Deviation is a measure of the volatility of a portfolio. Risk profile data is net. Performance Net of Fees 1
5-Year Risk Profile 5
Equity Regional Weights (%) 4 Group Exposures (%) 3,4
Equity Characteristics 4
Other Equity Absolute Return Cash U.S. Equity Intl. Developed Equity Emerging Equity Fixed Income Tot al Retur n (%) Aver age Annual Total Retur n (%) 2Q YTD One Five Ten Since 2014 2014 Year Year Year Inception Strategy 2.92 4.61 13.40 8.92 6.90 8.12 Benchmark 2 3.89 5.46 15.71 10.93 6.33 7.48 Annual Tot al Retur n (%) 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Strategy 12.73 9.91 12.08 7.16 -14.95 14.29 6.88 1.34 9.71 10.86 Benchmark 10.02 5.91 12.95 7.12 -25.89 23.90 9.99 -0.27 11.47 12.78 St r at egy Benchmar k Alpha -0.02 0.00 Beta 0.82 1.00 R 2 0.96 1.00 Sharpe Ratio 1.18 1.21 Std. Deviation 7.50 9.00 0 20 40 60 80 100 U.S. Quality, 13.1 Europe Value, 19.9 Other Int'l. Opportunistic Value, 1.2 Emerging Markets, 7.1 Cash & Cash Equiv., 2.8 Municipal Bonds, 32.0 Emerging Country Debt, 2.3 Risk Premium, 2.1 J apan, 3.5 U.S. Opportunistic Value, 2.6 Multi-Strategy, 13.3 U.S. Small, 0.1 15.2 31.9 7.3 2.3 10.1 33.2 10.9 16.8 7.4 8.3 7.8 48.9 0 20 40 60 Emerging Europe ex UK J apan Other International United Kingdom United States Strategy Benchmark St r at egy Benchmar k Price/Earnings - Hist 1 Yr Wtd Med 16.0 x 16.0 x Price/Cash Flow - Hist 1 Yr Wtd Med 1.7 x 1.7 x Price/Book - Hist 1 Yr Wtd Avg 1.7 x 1.7 x Return on Equity - Hist 1 Yr Med 13.1 % 13.1 % Market Cap - Weighted Median $Bil $41.3 $41.3 Dividend Yield - Hist 1 Yr Wtd Avg 3.0 % 3.0 % 12 As of June 30, 2014 GMO 2014 Quarterly Strategy Attribution Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. GMO Tax-Managed Global Balanced Strategy Inception: 12/31/02; Benchmark: GMO Tax-Managed Global Balanced Index 13 As of June 30, 2014 GMO 2014 5-Year Risk Profile 5
Top Holdings 4,6
Top Country Weights (%) 4 Group Exposures (%) 3,4
Characteristics 4
Performance Net of Fees 1
GMO Global All Country Equity Allocation Strategy Inception: 12/31/93; Benchmark: MSCI All Country World Index 1 Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. 2 The GMO blended Global All Country Equity Allocation Composite benchmark is comprised of a weighted average of account benchmarks; many of the account benchmarks consist of MSCI ACWI (All Country World Index) (MSCI standard Index Series, net of withholding tax) or some like proxy for each market exposure they have. For each underlying account benchmark, the weighting of each market index will vary slightly. The index is internally blended by GMO and maintained on a monthly basis. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder. 3 The groups indicated above represent exposures determined pursuant to proprietary methodologies and are subject to change over time. 4 The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the Strategy. 5 Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R 2 is a measure of how well a portfolio tracks the market; Sharpe Ratio is the return over the risk free rate per unit of risk; Std. Deviation is a measure of the volatility of a portfolio. Risk profile data is net. 6 Portfolio holdings are subject to change and should not be considered a recommendation to buy individual securities. Tot al Ret ur n (%) Aver age Annual Tot al Ret ur n (%) 2Q YTD One Five Ten Since 2014 2014 Year Year Year Inception Strategy 4.91 7.06 22.57 14.13 8.79 9.58 Benchmark 2 5.04 6.19 23.10 14.62 7.35 7.73 Annual Tot al Ret ur n (%) 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Strategy 17.62 12.51 18.87 11.12 -31.41 24.19 10.12 -1.29 14.74 21.33 Benchmark 14.86 9.95 20.34 10.38 -41.82 34.45 12.94 -6.87 16.34 23.46 St r at egy Benchmar k Alpha 1.29 0.00 Beta 0.88 1.00 R 2 0.97 1.00 Sharpe Ratio 1.06 0.98 Std. Deviation 13.25 14.83 0 20 40 60 80 100 U.S. Quality, 26.8 Europe Value, 39.3 Other Int'l. Opportunistic Value, 2.2 Emerging Markets, 12.8 Cash & Cash Equiv., 2.3 J apan, 8.4 U.S. Opportunistic Value, 8.2 U.S. Equity Intl. Developed Equity Emerging Equity Cash St r at egy Benchmar k Price/Earnings - Hist 1 Yr Wtd Med 15.6 x 18.4 x Price/Book - Hist 1 Yr Wtd Avg 1.6 x 2.1 x Return on Equity - Hist 1 Yr Med 11.2 % 14.3 % Market Cap - Weighted Median $Bil $46.6 $40.0 Dividend Yield - Hist 1 Yr Wtd Avg 3.1 % 2.5 % Company Count r y Sect or % of Equi t y Total S.A. France Energy 2.8 Royal Dutch Shell PLC United Kingdom Energy 2.4 Oracle Corp. United States Information Technology 1.9 BP PLC United Kingdom Energy 1.9 Philip Morris International United States Consumer Staples 1.8 Total 10.8 35.4 9.7 9.0 8.3 8.2 48.9 3.7 7.8 7.4 3.4 0 20 40 60 United States France United Kingdom J apan Germany Strategy Benchmark 14 As of June 30, 2014 GMO 2014 Quarterly Strategy Attribution Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. GMO Global All Country Equity Allocation Strategy Inception: 12/31/93; Benchmark: MSCI All Country World Index 15 As of June 30, 2014 GMO 2014 5-Year Risk Profile 5
Top Holdings 4,6
Top Country Weights (%) 4 Group Exposures (%) 3,4
Characteristics 4
Performance Net of Fees 1
1 Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. 2 The GMO blended Global Developed Equity Allocation Composite benchmark is comprised of a weighted average of account benchmarks; many of the account benchmarks consist of MSCI World (MSCI Standard Index Series, net of withholding tax) or some like proxy for each market exposure they have. For each underlying account benchmark, the weighting of each market index will vary slightly. The index is internally blended by GMO and maintained on a monthly basis. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder. 3 The groups indicated above represent exposures determined pursuant to proprietary methodologies and are subject to change over time. 4 The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the Strategy. 5 Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R 2 is a measure of how well a portfolio tracks the market; Sharpe Ratio is the return over the risk free rate per unit of risk; Std. Deviation is a measure of the volatility of a portfolio. Risk profile data is net. 6 Portfolio holdings are subject to change and should not be considered a recommendation to buy individual securities. GMO Global Developed Equity Allocation Strategy Inception: 3/31/87; Benchmark: MSCI World Index Tot al Ret ur n (%) Aver age Annual Tot al Ret ur n (%) 2Q YTD One Five Ten Since 2014 2014 Year Year Year Inception Strategy 4.79 7.58 24.57 14.87 8.44 9.79 Benchmark 2 4.86 6.18 24.05 15.00 7.13 7.64 Annual Tot al Ret ur n (%) 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Strategy 17.36 12.26 20.22 9.69 -33.19 20.55 9.25 -0.40 14.14 25.82 Benchmark 13.64 9.42 20.05 9.02 -40.70 29.97 11.77 -5.52 15.84 26.68 St r at egy Benchmar k Alpha 1.51 0.00 Beta 0.89 1.00 R 2 0.97 1.00 Sharpe Ratio 1.12 1.02 Std. Deviation 13.19 14.58 0 20 40 60 80 100 U.S. Quality, 26.6 Europe Value, 42.0 Other Int'l. Opportunistic Value, 2.4 Emerging Markets, 9.6 Cash & Cash Equiv., 2.3 J apan, 9.0 U.S. Opportunistic Value, 8.2 U.S. Equity Intl. Developed Equity Emerging Equity Cash St r at egy Benchmar k Price/Earnings - Hist 1 Yr Wtd Med 15.7 x 18.7 x Price/Book - Hist 1 Yr Wtd Avg 1.6 x 2.2 x Return on Equity - Hist 1 Yr Med 11.1 % 14.5 % Market Cap - Weighted Median $Bil $46.7 $46.2 Dividend Yield - Hist 1 Yr Wtd Avg 3.1 % 2.4 % Company Count r y Sect or % of Equi t y Total S.A. France Energy 3.0 Royal Dutch Shell PLC United Kingdom Energy 2.5 BP PLC United Kingdom Energy 2.0 Oracle Corp. United States Information Technology 1.9 Philip Morris International United States Consumer Staples 1.8 Total 11.2 35.1 10.4 9.6 8.9 8.8 54.8 4.1 8.8 8.3 3.8 0 20 40 60 United States France United Kingdom J apan Germany Strategy Benchmark 16 As of June 30, 2014 GMO 2014 Quarterly Strategy Attribution Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. GMO Global Developed Equity Allocation Strategy Inception: 3/31/87; Benchmark: MSCI World Index 17 As of June 30, 2014 GMO 2014 GMO Global Focused Equity Strategy Inception: 12/31/11 Performance Net of Fees 1 Top Ten Holdings 2,5
Sector Weights 5
GICS Sectors Region Weights 5
1 Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. 2 Portfolio holdings are percent of equity. They are subject to change and should not be considered a recommendation to buy individual securities. 3 The Global Focused Equity Strategy does not have a benchmark. The Strategy has been compared to the MSCI All Country World Index in an effort to compare and contrast the Strategy versus a broad global equity index. The MSCI ACWI (All Country World) Index (MSCI Standard Index Series, net of withholding tax) is an independently maintained and widely published index comprised of global developed and emerging markets. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder. 4 Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R 2 is a measure of how well a portfolio tracks the market; Sharpe Ratio is the return over the risk free rate per unit of risk; Std. Deviation is a measure of the volatility of a portfolio. Risk profile data is net. 5 The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the Strategy. Risk Profile Since 12/31/11 4 Characteristics 5
Tot al Ret ur n (%) Aver age Annual Tot al Ret ur n (%) 2Q YTD One Five Ten Since 2014 2014 Year Year Year Inception Strategy 5.38 6.15 32.21 N/A N/A 22.72 Benchmark 3 5.04 6.18 22.95 N/A N/A 18.05 Annual Tot al Ret ur n (%) 2012 2013 Strategy 19.71 31.29 Benchmark 16.13 22.80 St r at egy Benchmar k Alpha 0.35 0.00 Beta 1.24 1.00 R 2 0.85 1.00 Sharpe Ratio 1.56 1.67 Std. Deviation 14.54 10.81 Samsung Electronics Co. 3.6% ITT Corp 2.3% Comcast Corp. 2.3% China Unicom Ltd. 2.3% TriMas Corp. 2.3% National-Oilwell Inc. 2.2% Methanex Corp. 2.2% Capital Product Partners LP 2.2% MagnaChip Semiconductor 2.2% KapStone Paper & Pack. 2.2% Total 23.8% St r at egy Benchmar k Price/Earnings - Hist 1 Yr Wtd Med 16.0 x 18.4 x Price/Cash Fl ow - Hist 1 Yr Wtd Med 11.0 x 12.8 x Price/Book - Hist 1 Yr Wtd Avg 1.7 x 2.1 x Dividend Yiel d - Hist 1 Yr Wtd Avg 1.9 % 2.5 % Under wei ght /Over wei ght Regi on Agai nst Benchmar k (%) Australia/New Zealand Canada Emerging Europe ex UK Japan Southeast Asia United Kingdom United States Cash + Unrealized G/L 2.2 0.0 -0.2 -1.0 -0.2 0.6 -1.0 -3.3 2.6 -4 -2 0 2 4 Under wei ght /Over wei ght Sect or Agai nst Benchmar k St r at egy Benchmar k Consumer Discretionary 15.7 % 11.6 % Consumer Staples 1.7 9.6 Energy 14.3 10.2 Financials 17.0 21.3 Health Care 8.1 10.6 Industrials 11.8 10.7 Information Technology 15.4 12.8 Materials 11.7 6.1 Telecom. Services 2.3 3.8 Utilities 1.9 3.4 -1.5 -1.5 5.6 2.6 1.1 -2.5 -4.3 4.1 -7.9 4.1 -10 -5 0 5 10 18 As of June 30, 2014 GMO 2014 Quarterly Strategy Attribution Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. GMO Global Focused Equity Strategy Inception: 12/31/11 The Global Focused Equity Strategy rose 5.4% net of fees for the quarter. The strategys reference benchmark, MSCI All Country World index gained 5.0%.
Large positive contributions came from holdings in Suncor Energy in Canada and American Airlines in the United States. Suncor, Canada's largest oil and gas company, outperformed over the quarter as the oil price rose. Concerns about increasing violence in Iraq have boosted the Energy sector as the higher oil price has increased profits and shipment bottlenecks for the Canadian companies have been addressed. American Airlines (AAL) continues to be a significant beneficiary of industry-wide improvements. In particular, higher load factors, better base and ancillary pricing, and capacity discipline all drive margin expansion and earnings growth in the intermediate term. As the last legacy airline to merge, AAL has company-specific catalysts, including cost synergies and re-fleeting fuel inefficient aircraft, but also has committed to announcing a plan for reducing elevated cash levels through a significant share repurchase plan.
The largest detractors from performance were Topps Tiles in the United Kingdom and United Continental in the United States. Topps Tiles fell due to investors selling interest-rate-sensitive stocks in anticipation of imminent rate rises as U.K. economic data continued to surprise on the upside. We view the de-rating as significantly overdone and think the market is underestimating the recovery potential in stocks such as Topps given the depths of the recent recession. As a consequence, we recently added to the position. For United, despite poor execution in the wake of its merger with Continental Airlines, the company still offers the most robust earnings recovery in the industry, as it is poised to nearly double earnings from 2014 to 2016. It is true that it has squandered favorable industry conditions, and though it has the same revenue base as Delta, it is half as profitable. We believe that United Continental is poised to close this margin gap in the coming years. The company has announced over $2 billion of internal cost opportunities that it will complete in the next three years. It has significant opportunities to improve its yield management results as well as its route optimization and scheduling system. The severe weather in the first quarter and subsequent earnings miss caused investors to lose confidence in this management team, but we believe that the stock offers significant upside with any earnings recovery. 19 As of June 30, 2014 GMO 2014 GMO Quality Strategy Inception: 2/29/04; Benchmark: S&P 500 Index GICS Sectors 5-Year Risk Profile 4
Top Holdings 3,5
Sector Weights (%) 3 Region Weights (%) 3
Characteristics 3
Performance Net of Fees 1
1 Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. 2 The S&P 500 Index is an independently maintained and widely published index comprised of U.S. large capitalization stocks. S&P does not guarantee the accuracy, adequacy, completeness or availability of any data or information and is not responsible for any errors or omissions from the use of such data or information. Reproduction of the data or information in any form is prohibited except with the prior written permission of S&P or its third party licensors. 3 The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the Strategy. 4 Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R 2 is a measure of how well a portfolio tracks the market; Sharpe Ratio is the return over the risk free rate per unit of risk; Std. Deviation is a measure of the volatility of a portfolio. Risk profile data is net. 5 Portfolio holdings are subject to change and should not be considered a recommendation to buy individual securities. Annual Tot al Ret ur n (%) 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Strategy 3.54 -0.79 12.69 6.04 -24.08 19.89 5.48 11.84 11.81 25.47 Benchmark 7.39 4.91 15.80 5.49 -37.00 26.46 15.06 2.11 16.00 32.39 St r at egy Benchmar k Alpha 1.33 0.00 Beta 0.77 1.00 R 2 0.86 1.00 Sharpe Ratio 1.43 1.41 Std. Deviation 11.01 13.29 10.2 88.8 1.0 0.0 100.0 0.0 0 20 40 60 80 100 Non U.S. U.S. Cash Strategy Benchmark 5.9 22.8 5.3 0.0 23.5 6.7 33.7 1.0 1.2 0.0 11.9 9.5 10.9 16.1 13.2 10.5 18.9 3.5 2.4 3.2 0 10 20 30 40 Consumer Discretionary Consumer Staples Energy Financials Health Care Industrials Information Technology Materials Telecommunication Services Utilities Strategy Benchmark St r at egy Benchmar k Price/Earnings - Hist 1 Yr Wtd Med 19.6 x 19.5 x Price/Book - Hist 1 Yr Wtd Avg 3.9 x 2.7 x Return on Equity - Hist 1 Yr Med 20.1 % 17.4 % Market Cap - Weighted Median $Bil $132.9 $68.3 Debt/Equity Wtd Med 0.5 x 0.8 x Dividend Yield - Hist 1 Yr Wtd Avg 2.2 % 2.0 % Company Sect or % of Equi t y Microsoft Corp. Information Technology 5.0 Philip Morris Int'l. Inc. Consumer Staples 4.8 Oracle Corp. Information Technology 4.6 Johnson & Johnson Health Care 4.4 Apple Inc. Information Technology 4.3 Total 23.1 Tot al Ret ur n (%) Aver age Annual Tot al Ret ur n (%) 2Q YTD One Five Ten Since 2014 2014 Year Year Year Inception Strategy 3.69 5.77 17.59 15.85 6.89 6.71 Benchmark 2 5.23 7.14 24.61 18.83 7.78 7.54 20 As of June 30, 2014 GMO 2014 Quarterly Strategy Attribution Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. GMO Quality Strategy Inception: 2/29/04; Benchmark: S&P 500 Index 21 As of June 30, 2014 GMO 2014 GMO Resources Strategy Inception: 12/31/11; Benchmark: MSCI ACWI Commodity Producers Index Performance Net of Fees 1
Top Country Weights (%) 3
Risk Profile Since 12/31/11 4
Top Holdings 3,5
Sector Weights (%) 3
Characteristics 3
1 Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. 2 The MSCI ACWI (All Country World) Commodity Producers Index (MSCI Standard Index Series, net of withholding tax) is an independently maintained and widely published index comprised of listed large and mid capitalization commodity producers within the global developed and emerging markets. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder. 3 The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the Strategy. 4 Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R 2 is a measure of how well a portfolio tracks the market; Sharpe Ratio is the return over the risk free rate per unit of risk; Std. Deviation is a measure of the volatility of a portfolio. Risk profile data is net. 5 Portfolio holdings are subject to change and should not be considered a recommendation to buy individual securities. Annual Tot al Ret ur n (%) 2012 2013 Strategy 9.23 4.39 Benchmark 1.96 3.31 St r at egy Benchmar k Alpha 4.09 0.00 Beta 1.05 1.00 R 2 0.96 1.00 Sharpe Ratio 0.64 0.39 Std. Deviation 16.01 14.93 17.5 12.3 11.9 10.1 8.6 38.8 18.5 1.8 3.5 1.2 0 10 20 30 40 United States United Kingdom J apan Russia Norway Strategy Benchmark 0.0 1.7 76.0 0.0 0.0 10.2 0.0 6.8 0.0 5.3 0.0 1.5 70.5 0.0 0.0 0.0 0.0 28.0 0.0 0.0 0 20 40 60 80 Consumer Discretionary Consumer Staples Energy Financials Health Care Industrials Information Technology Materials Telecommunication Services Utilities Strategy Benchmark GICS Sectors St r at egy Benchmar k Price/Earnings - Hist 1 Yr Wtd Med 12.2 x 14.2 x Earnings/Share - Forecast LT Median Growth Rate 6.0 x 7.0 x Return on Equity - Hist 1 Yr Med 10.5 % 11.6 % Market Cap - Weighted Median $Bil $34.3 $59.1 Dividend Yiel d - Hist 1 Yr Wtd Avg 3.9 % 3.0 % Company Count r y Sect or % of Equi t y Petroleo Brasileiro S/A Brazil Energy 5.1 Chevron Corp. United States Energy 5.0 BP PLC United Kingdom Energy 5.0 Total S.A. France Energy 5.0 CNOOC Ltd. China Energy 4.9 Total 25.0 Tot al Ret ur n (%) Aver age Annual Tot al Ret ur n (%) 2Q YTD One Five Ten Since 2014 2014 Year Year Year Inception Strategy 10.58 11.86 29.14 N/A N/A 10.22 Benchmark 2 9.28 9.39 24.97 N/A N/A 5.83 22 As of June 30, 2014 GMO 2014 Quarterly Strategy Attribution Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. GMO Resources Strategy Inception: 12/31/11; Benchmark: MSCI ACWI Commodity Producers Index 23 As of June 30, 2014 GMO 2014 GMO International All Country Equity Allocation Strategy Inception: 2/28/94; Benchmark: MSCI All Country World ex USA Index 1 Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. 2 The GMO blended International All Country Equity Allocation Composite benchmark is comprised of a weighted average of account benchmarks; many of the account benchmarks consist of MSCI ACWI (All Country World Index) ex USA (MSCI Standard Index Series, net of withholding tax) or some like proxy for each market exposure they have. For each underlying account benchmark, the weighting of each market index will vary slightly. The index is internally blended by GMO and maintained on a monthly basis. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder. 3 The groups indicated above represent exposures determined pursuant to proprietary methodologies and are subject to change over time. 4 The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the Strategy. 5 Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R 2 is a measure of how well a portfolio tracks the market; Sharpe Ratio is the return over the risk free rate per unit of risk; Standard Deviation is a measure of the volatility of a portfolio. Risk profile data is net. 6 Portfolio holdings are subject to change and should not be considered a recommendation to buy individual securities. Performance Net of Fees 1
5-Year Risk Profile 5
Top Holdings 4,6
Top Country Weights (%) 4 Group Exposures (%) 3,4
Tot al Ret ur n (%) Aver age Annual Tot al Ret ur n (%) 2Q YTD One Five Ten Since 2014 2014 Year Year Year Inception Strategy 5.91 7.89 26.40 12.16 8.72 8.20 Benchmark 2 5.01 5.54 21.78 11.07 7.69 6.17 Annual Tot al Ret ur n (%) 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Strategy 24.06 19.03 25.91 17.39 -40.96 27.77 12.74 -11.31 16.82 16.71 Benchmark 21.11 16.71 26.94 16.08 -45.26 40.16 10.82 -13.63 16.90 15.47 U.S. Equity Intl. Developed Equity Emerging Equity Cash Characteristics 4
Company Count r y Sect or % of Equi t y Total S.A. France Energy 4.2 Royal Dutch Shell PLC United Kingdom Energy 3.6 BP PLC United Kingdom Energy 2.9 DaimlerChrysler AG Germany Consumer Discretionary 2.0 Telefonica S.A. Spain Telecommunication Services 2.0 Total 14.7 St r at egy Benchmar k Price/Earnings - Hist 1 Yr Wtd Med 14.2 x 16.9 x Price/Book - Hist 1 Yr Wtd Avg 1.2 x 1.7 x Return on Equity - Hist 1 Yr Med 9.4 % 11.7 % Market Cap - Weighted Median $Bil $27.9 $26.1 Dividend Yield - Hist 1 Yr Wtd Avg 3.7 % 2.9 % St r a t egy Benchmar k Al pha 1.41 0.00 Beta 0.97 1.00 R 2 0.98 1.00 Shar pe Rati o 0.73 0.66 Std. Devi ati on 16.48 16.76 0 20 40 60 80 100 U.S. Quality, 0.2 Europe Value, 59.1 Other Int'l. Opportunistic Value, 3.3 Emerging Markets, 22.4 Cash & Cash Equiv., 2.4 J apan, 12.6 14.6 13.5 12.5 12.4 4.7 7.2 15.3 14.4 6.6 1.9 0 5 10 15 20 France United Kingdom J apan Germany Italy Strategy Benchmark 24 As of June 30, 2014 GMO 2014 Quarterly Strategy Attribution Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. GMO International All Country Equity Allocation Strategy Inception: 2/28/94; Benchmark: MSCI All Country World ex USA Index 25 As of June 30, 2014 GMO 2014 GMO International Developed Equity Allocation Strategy Inception: 11/30/91; Benchmark: MSCI EAFE Index Performance Net of Fees 1
Group Exposures (%) 3
Tot al Ret ur n (%) Aver age Annual Tot al Ret ur n (%) 2Q YTD One Five Ten Since 2014 2014 Year Year Year Inception Strategy 5.54 9.02 30.16 13.28 8.31 8.96 Benchmark 2 4.09 4.78 23.57 11.82 7.20 6.79 Annual Tot al Ret ur n (%) 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Strategy 24.89 15.56 25.50 12.69 -38.39 19.84 10.58 -9.45 17.09 24.13 Benchmark 21.17 14.41 26.62 11.58 -43.33 32.16 7.93 -12.14 17.32 22.78 5-Year Risk Profile 5
Top Holdings 4,6
Top Country Weights (%) 4
Characteristics 4
St r a t egy Benchmar k Al pha 2.19 0.00 Beta 0.94 1.00 R 2 0.97 1.00 Shar pe Rati o 0.82 0.69 Std. Devi ati on 16.11 16.93 Company Count r y Sect or % of Equi t y Total S.A. France Energy 4.9 Royal Dutch Shell PLC United Kingdom Energy 4.2 BP PLC United Kingdom Energy 3.4 DaimlerChrysler AG Germany Consumer Discretionary 2.4 Telefonica S.A. Spain Telecommunication Services 2.4 Total 17.3 St r at egy Benchmar k Price/Earnings - Hist 1 Yr Wtd Med 14.2 x 17.5 x Price/Book - Hist 1 Yr Wtd Avg 1.3 x 1.7 x Return on Equity - Hist 1 Yr Med 9.7 % 11.2 % Market Cap - Weighted Median $Bil $29.5 $35.4 Dividend Yield - Hist 1 Yr Wtd Avg 3.6 % 3.0 % 1 Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. 2 The GMO blended International Developed Equity Allocation Composite benchmark is comprised of a weighted average of account benchmarks; many of the account benchmarks consist of MSCI EAFE (MSCI Standard Index Series, net of withholding tax) or some like proxy for each market exposure they have. For each underlying account benchmark, the weighting of each market index will vary slightly. The index is internally blended by GMO and maintained on a monthly basis. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder. 3 The groups indicated above represent exposures determined pursuant to proprietary methodologies and are subject to change over time. 4 The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the Strategy. 5 Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R 2 is a measure of how well a portfolio tracks the market; Sharpe Ratio is the return over the risk free rate per unit of risk; Standard Deviation is a measure of the volatility of a portfolio. Risk profile data is net. 6 Portfolio holdings are subject to change and should not be considered a recommendation to buy individual securities. U.S. Equity Intl. Developed Equity Emerging Equity Cash 0 20 40 60 80 100 U.S. Quality, 0.1 Europe Value, 69.0 Other Int'l. Opportunistic Value, 3.8 Emerging Markets, 9.6 Cash & Cash Equiv., 2.7 J apan, 14.8 17.2 15.9 14.8 14.6 5.5 10.1 21.4 20.2 9.3 2.6 0 5 10 15 20 25 France United Kingdom J apan Germany Italy Strategy Benchmark 26 As of June 30, 2014 GMO 2014 Quarterly Strategy Attribution Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. GMO International Developed Equity Allocation Strategy Inception: 11/30/91; Benchmark: MSCI EAFE Index 27 As of June 30, 2014 GMO 2014 GMO International Equity Strategy Inception: 3/31/87; Benchmark: MSCI EAFE Index Performance Net of Fees 1
(The GMO International Equity Strategy was formerly known as the GMO International Intrinsic Value Strategy. GMO renamed the Strategy on June 30, 2014.) Group Exposures (%) 3
5-Year Risk Profile 5
Top Holdings 4,6
Top Country Weights (%) 4
Characteristics 4
1 Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. 2 The MSCI EAFE (Europe, Australasia, and Far East) Index (MSCI Standard Index Series, net of withholding tax) is an independently maintained and widely published index comprised of international large and mid capitalization stocks. The MSCI EAFE + (Europe, Australasia, and Far East) Index is an internally maintained benchmark computed by GMO, comprised of (i) the MSCI EAFE (Europe, Australasia, and Far East) Value Index (MSCI Standard Index Series, net of withholding tax) through 06/30/2014 and (ii) the MSCI EAFE (Europe, Australasia, and Far East) Index (MSCI Standard Index Series, net of withholding tax) thereafter. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder. 3 The groups indicated above represent exposures determined pursuant to proprietary methodologies and are subject to change over time. 4 The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the Strategy. 5 Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R 2 is a measure of how well a portfolio tracks the market; Sharpe Ratio is the return over the risk free rate per unit of risk; Std. Deviation is a measure of the volatility of a portfolio. Risk profile data is net. 6 Portfolio holdings are subject to change and should not be considered a recommendation to buy individual securities. St r at egy Benchmar k Price/Earnings - Hist 1 Yr Wtd Med 14.5 x 17.5 x Price/Cash Fl ow - Hist 1 Yr Wtd Med 6.5 x 10.9 x Price/Book - Hist 1 Yr Wtd Avg 1.3 x 1.7 x Return on Equity - Hist 1 Yr Med 9.8 % 11.2 % Market Cap - Weighted Median $Bil $36.1 $35.4 Dividend Yield - Hist 1 Yr Wtd Avg 3.6 % 3.0 % Company Count r y Sect or % of Equi t y Total S.A. France Energy 5.5 Royal Dutch Shell PLC United Kingdom Energy 4.7 BP PLC United Kingdom Energy 3.8 DaimlerChrysler AG Germany Consumer Discretionary 2.6 Telefonica S.A. Spain Telecommunication Services 2.6 Total 19.2 0 20 40 60 80 100 Europe Value, 76.4 Other Int'l. Opportunistic Value, 4.1 Cash & Cash Equiv., 3.0 J apan, 16.4 Intl. Developed Equity Cash 19.1 17.6 16.4 16.2 6.1 10.1 21.4 20.2 9.3 2.6 0 5 10 15 20 25 France United Kingdom J apan Germany Italy Strategy Benchmark Tot al Ret ur n (%) Aver age Annual Total Retur n (%) 2Q YTD One Five Ten Since 2014 2014 Year Year Year Inception Strategy 5.22 8.73 32.01 11.75 7.07 8.62 MSCI EAFE 2 4.09 4.78 23.57 11.77 6.93 5.70 MSCI EAFE + 2 4.73 6.01 26.86 11.24 6.71 7.48 Annual Total Retur n (%) 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Strategy 25.23 13.98 25.78 10.21 -40.31 21.41 7.53 -10.18 12.98 25.62 MSCI EAFE 20.25 13.54 26.34 11.17 -43.38 31.78 7.75 -12.14 17.32 22.78 MSCI EAFE + 24.33 13.80 30.38 5.96 -44.09 34.23 3.25 -12.17 17.69 22.95 St r at egy MSCI EAFE + Alpha 1.39 0.00 Beta 0.92 1.00 R 2 0.98 1.00 Sharpe Ratio 0.70 0.62 Std. Deviation 16.72 17.96 28 As of June 30, 2014 GMO 2014 Quarterly Strategy Attribution Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. Quarterly Strategy Attribution GMO International Equity Strategy Inception: 3/31/87; Benchmark: MSCI EAFE Index (The GMO International Equity Strategy was formerly known as the GMO International Intrinsic Value Strategy. GMO renamed the Strategy on June 30, 2014.) 29 As of June 30, 2014 GMO 2014 GMO International Active EAFE Strategy Inception: 5/31/81; Benchmark: MSCI EAFE Index Performance Net of Fees 1 Top Overweight Holdings 2,5
5-Year Risk Profile 4
1 Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. 2 Portfolio holdings are percent of equity. They are subject to change and should not be considered a recommendation to buy individual securities. 3 The MSCI EAFE (Europe, Australasia, and Far East) Index (MSCI Standard Index Series, net of withholding tax) is an independently maintained and widely published index comprised of international large and mid capitalization stocks. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder. 4 Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R 2 is a measure of how well a portfolio tracks the market; Sharpe Ratio is the return over the risk free rate per unit of risk; Standard Deviation is a measure of the volatility of a portfolio. Risk profile data is net. 5 The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the Strategy. Sector Weights 5
GICS Sectors Region Weights 5
Characteristics 5
Tot al Ret ur n (%) Aver age Annual Tot al Ret ur n (%) 2Q YTD One Five Ten Since 2014 2014 Year Year Year Inception Strategy 2.99 1.93 21.97 10.39 6.34 12.15 Benchmark 3 4.09 4.78 23.57 11.77 6.93 9.32 Annual Tot al Ret ur n (%) 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Strategy 22.33 13.52 27.52 10.58 -41.24 25.53 5.01 -11.65 14.92 24.11 Benchmark 20.25 13.54 26.34 11.17 -43.38 31.78 7.75 -12.14 17.32 22.78 Under wei ght /Over wei ght Regi on Agai nst Benchmar k (%) Australia/New Zealand Emerging Europe ex UK Japan Southeast Asia United Kingdom Cash + Unrealized G/L -5.4 5.7 6.0 -2.6 -2.0 -2.7 0.9 -10 -5 0 5 10 Under wei ght /Over wei ght Sect or Agai nst Benchmar k St r at egy Benchmar k Consumer Discretionary 13.5 % 11.9 % Consumer Staples 6.7 11.1 Energy 13.2 7.3 Financials 24.7 25.3 Health Care 4.7 10.5 Industrials 10.3 12.7 Information Technology 8.6 4.4 Materials 4.0 8.0 Telecom. Services 4.2 4.9 Utilities 10.0 3.9 6.1 -0.7 -4.0 4.2 -2.4 -5.8 -0.6 5.9 -4.4 1.6 -10 -5 0 5 10 St r a t egy Benchmar k Al pha -1.40 0.00 Beta 1.00 1.00 R 2 0.98 1.00 Shar pe Rati o 0.60 0.69 Std. Devi ati on 17.09 16.90 St r at egy Benchmar k Price/Earnings - Hist 1 Yr Wtd Med 16.3 x 17.5 x Price/Cash Fl ow - Hist 1 Yr Wtd Med 7.5 x 10.9 x Price/Book - Hist 1 Yr Wtd Avg 1.4 x 1.7 x Dividend Yiel d - Hist 1 Yr Wtd Avg 2.9 % 3.0 % Peugeot S.A. 3.2% Sumitomo Mitsui Financial 3.1% Mitsubishi Tokyo Financial 3.0% Samsung Electronics Co. 3.0% E.ON AG 2.9% RWE AG 2.0% Eni S.p.A. 1.9% Nokia Corp. 1.8% Repsol YPF S.A. 1.4% British American Tobacco 1.3% 30 As of June 30, 2014 GMO 2014 Quarterly Strategy Attribution Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. GMO International Active EAFE Strategy Inception: 5/31/81; Benchmark: MSCI EAFE Index The International Active EAFE Strategy gained 3.0% net of fees in the second quarter, 1.1 percentage points behind the MSCI EAFE index, which returned +4.1%.
Country selection was behind the benchmark. Our positioning in Continental Europe subtracted from returns, particularly overweight positions in Italy and France, which underperformed in the quarter.
Stock selection also lagged the benchmark in the second quarter. Holdings in the United Kingdom and Japan underperformed. On the positive side, stock selection in Continental Europe helped returns. 31 As of June 30, 2014 GMO 2014 GMO Intl. Active Foreign Small Companies Strategy Inception: 1/31/95; Benchmark: S&P Developed ex-U.S. Small Cap Index Performance Net of Fees 1 Top Overweight Holdings 2,5
5-Year Risk Profile 4
1 Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. 2 Portfolio holdings are percent of equity. They are subject to change and should not be considered a recommendation to buy individual securities. 3 The S&P Developed ex-U.S. Small Cap Index is an independently maintained and widely published index comprised of the small capitalization stock component of the S&P Broad Market Index (BMI). The BMI includes listed shares of companies from developed and emerging countries with a total available market capitalization (float) of at least the local equivalent of $100 million USD. The S&P Developed ex-U.S. Small Cap Index represents the bottom 15% of available market capitalization (float) of the BMI in each country. 4 Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R 2 is a measure of how well a portfolio tracks the market; Sharpe Ratio is the return over the risk free rate per unit of risk; Standard Deviation is a measure of the volatility of a portfolio. Risk profile data is net. 5 The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the Strategy. Sector Weights 5 Region Weights 5
Characteristics 5
GICS Sectors Tot al Ret ur n (%) Aver age Annual Tot al Ret ur n (%) 2Q YTD One Five Ten Since 2014 2014 Year Year Year Inception Strategy 1.90 5.02 25.85 17.31 11.13 11.94 Benchmark 3 3.40 7.24 29.95 15.47 9.64 7.90 Annual Tot al Ret ur n (%) 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Strategy 29.30 18.91 36.24 8.00 -45.91 47.63 24.76 -15.21 21.64 28.92 Benchmark 28.73 22.10 29.42 7.32 -47.67 45.07 21.96 -14.49 18.55 26.06 St r at egy Benchmar k Price/Earnings - Hist 1 Yr Wtd Med 19.2 x 20.2 x Price/Cash Fl ow - Hist 1 Yr Wtd Med 11.4 x 12.2 x Price/Book - Hist 1 Yr Wtd Avg 1.6 x 1.6 x Dividend Yiel d - Hist 1 Yr Wtd Avg 2.1 % 2.3 % Under wei ght /Over wei ght Regi on Agai nst Benchmar k (%) Australia/New Zealand Canada Emerging Europe ex UK Japan Southeast Asia United Kingdom Cash + Unrealized G/L 0.6 -2.5 3.7 3.5 -2.8 -3.5 -1.2 2.3 -6 -3 0 3 6 Under wei ght /Over wei ght Sect or Agai nst Benchmar k St r at egy Benchmar k Consumer Discretionary 21.9 % 16.4 % Consumer Staples 3.2 5.6 Energy 7.5 4.9 Financials 20.9 21.6 Health Care 3.4 6.0 Industrials 24.2 23.0 Information Technology 8.4 8.8 Materials 9.5 10.3 Telecom. Services 0.9 1.2 Utilities 0.0 2.3 -2.3 -0.3 -0.8 -0.4 1.2 -2.6 -0.7 2.6 -2.4 5.5 -6 -3 0 3 6 St r at egy Benchmar k Al pha 2.49 0.00 Beta 0.96 1.00 R 2 0.98 1.00 Shar pe Rati o 1.03 0.89 Std. Devi ati on 16.66 17.20 Mediobanca Banca di Credito 1.4% Capstone Mining Corp. 1.3% Credito Emiliano S.p.A. 1.2% Asciano Group 1.2% NuVista Energy Ltd. 1.2% Incitec Pivot Ltd. 1.2% Groupe Steria S.C.A. 1.2% Rheinmetall AG 1.2% Precision Drilling Corp. 1.1% Vicat S.A. 1.1% 32 As of June 30, 2014 GMO 2014 Quarterly Strategy Attribution Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. The International Active Foreign Small Companies Strategy underperformed the S&P Developed ex-U.S. Small Cap index by 1.5 percentage points in the second quarter, gaining 1.9% net of fees while the benchmark rose 3.4%.
Country selection was behind the benchmark in the quarter. Our positioning in Continental Europe hurt returns, particularly overweight positions in Italy and France, which underperformed in the quarter. An underweight position in Japan also subtracted from returns.
Stock selection outperformed the benchmark, but it was not enough to offset the negative country selection. Our holdings in Japan, Australia, and the emerging markets outperformed. Stock selection in Continental Europe and the United Kingdom hurt performance. GMO Intl. Active Foreign Small Companies Strategy Inception: 1/31/95; Benchmark: S&P Developed ex-U.S. Small Cap Index 33 As of June 30, 2014 GMO 2014 GMO U.S. Equity Allocation Strategy Inception: 2/28/89; Benchmark: Russell 3000 Index GICS Sectors 1 Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. 2 The GMO blended U.S. Equity Allocation Composite benchmark is comprised of a weighted average of account benchmarks; many of the account benchmarks consist of S&P 500, Russell 3000 or some like proxy for each market exposure they have. For each underlying account benchmark, the weighting of each market index will vary slightly. The index is internally blended by GMO and maintained on a monthly basis. Russell Investments is the source and owner of the Russell index data contained or reflected in this material and all trademarks and copyrights related thereto. The presentation may contain confidential information and unauthorized use, disclosure, copying, dissemination or redistribution is strictly prohibited. This is GMOs presentation of the data. FCR is not responsible for the formatting or configuration of this material or for any inaccuracy in GMOs presentation thereof. 3 The groups indicated above represent exposures determined pursuant to proprietary methodologies and are subject to change over time. 4 The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the Strategy. 5 Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R 2 is a measure of how well a portfolio tracks the market; Sharpe Ratio is the return over the risk free rate per unit of risk; Std. Deviation is a measure of the volatility of a portfolio. Risk profile data is net. 6 Portfolio holdings are subject to change and should not be considered a recommendation to buy individual securities. Performance Net of Fees 1
5-Year Risk Profile 5
Top Holdings 4,6
Sector Weights (%) 4 Group Exposures (%) 3,4
Characteristics 4
Tot al Ret ur n (%) Aver age Annual Tot al Retur n (%) 2Q YTD One Five Ten Since 2014 2014 Year Year Year Inception Strategy 3.34 5.53 18.05 16.46 6.90 10.83 Benchmark 2 5.23 7.14 24.86 19.15 8.05 10.36 Annual Tot al Retur n (%) 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Strategy 10.74 3.68 9.93 2.25 -27.87 20.54 7.43 9.91 12.25 27.95 Benchmark 11.45 5.53 15.71 5.39 -37.15 27.46 16.26 1.58 16.21 32.85 0 20 40 60 80 100 U.S. Quality, 74.9 U.S. Opportunistic Value, 23.1 Cash & Cash Equiv., 1.9 U.S. Equity Cash 5.1 17.1 12.7 5.3 18.9 6.3 33.5 1.2 0.0 0.0 11.9 9.5 10.9 16.1 13.2 10.5 18.9 3.5 2.4 3.2 0 10 20 30 40 Consumer Discretionary Consumer Staples Energy Financials Health Care Industrials Information Technology Materials Telecommunication Services Utilities Strategy Benchmark St r at egy Benchmar k Price/Earnings - Hist 1 Yr Wtd Median 17.7 x 19.5 x Price/Book - Hist 1 Yr Wtd Avg 3.2 x 2.7 x Return on Equity - Hist 1 Yr Median 21.8 % 17.4 % Market Cap - Weighted Median $Bil $132.9 $68.3 Dividend Yield - Hist 1 Yr Wtd Avg 2.1 x 2.0 x Company Sect or %of Equi t y Oracle Corp. Information Technology 5.3 Philip Morris Int'l. Inc. Consumer Staples 5.0 Chevron Corp. Energy 5.0 Microsoft Corp. Information Technology 4.7 Int'l. Business Machines Information Technology 4.3 Total 24.3 St r at egy Benchmar k Alpha 1.19 0.00 Beta 0.80 1.00 R 2 0.90 1.00 Sharpe Ratio 1.44 1.40 Std. Deviation 11.38 13.57 34 As of June 30, 2014 GMO 2014 Quarterly Strategy Attribution Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. GMO U.S. Equity Allocation Strategy Inception: 2/28/89; Benchmark: Russell 3000 Index 35 As of June 30, 2014 GMO 2014 GMO Emerging Markets Strategy Inception: 12/31/93; Benchmark: S&P/IFCI Composite Index Performance Net of Fees 1 Top Ten Holdings 2,5
5-Year Risk Profile 4
1 Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. 2 Portfolio holdings are percent of equity. They are subject to change and should not be considered a recommendation to buy individual securities. 3 The S&P/IFCI Composite Index is an independently maintained and widely published index comprised of emerging markets stocks. S&P does not guarantee the accuracy, adequacy, completeness or availability of any data or information and is not responsible for any errors or omissions from the use of such data or information. Reproduction of the data or information in any form is prohibited except with the prior written permission of S&P or its third party licensors. 4 Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R 2 is a measure of how well a portfolio tracks the market; Sharpe Ratio is the return over the risk free rate per unit of risk; Std. Deviation is a measure of the volatility of a portfolio. Risk profile data is net. 5 The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the Strategy. Sector Weights 5
GICS Sectors Region Weights 5
Characteristics 5
Tot al Ret ur n (%) Aver age Annual Tot al Retur n (%) 2Q YTD One Five Ten Since 2014 2014 Year Year Year Inception Strategy 8.13 4.95 13.39 8.51 11.07 8.05 Benchmark 3 7.51 6.82 16.00 10.14 12.91 6.28 Annual Total Ret ur n (%) 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Strategy 26.54 40.15 29.51 37.22 -55.74 71.89 20.20 -16.95 15.19 -5.19 Benchmark 28.11 35.19 35.11 40.28 -53.74 81.03 20.64 -19.03 18.89 -0.57 St r at egy Benchmar k Alpha -1.87 0.00 Beta 1.02 1.00 R 2 0.98 1.00 Sharpe Ratio 0.43 0.53 Std. Deviation 19.67 18.96 Samsung Electronics Co. Ltd. 3.9% Gazprom OAO 2.9% China Construction Bank 2.7% China Mobile Ltd. 2.6% Surgutneftegaz 2.6% LukOil OAO 2.5% KGHM Polska Miedz S.A. 2.3% Ind. & Comm. Bank of China 2.3% Banco do Brasil S.A. 2.1% Bank of China Ltd. 2.0% Total 25.9% St r at egy Benchmar k Price/Earnings - Hist 1 Yr Wtd Med 10.6 x 16.2 x Price/Cash Flow - Hist 1 Yr Wtd Med 5.9 x 10.0 x Price/Book - Hist 1 Yr Wtd Avg 1.1 x 1.5 x Return on Equity - Hist 1 Yr Avg 12.2 % 11.4 % Market Cap - Weighted Median $Bil $6.7 $7.3 Number of Equity Holdings 430 2,199 Dividend Yield - Hist 1 Yr Wtd Avg 4.1 % 2.7 % Under wei ght/Over wei ght Regi on Agai nst Benchmar k (%) Developed East Asia Europe Latin/South America Mideast/Africa South Asia Cash + Unrealized G/L 1.3 -8.3 13.9 -1.5 -4.1 -1.5 0.2 -20 -10 0 10 20 Under wei ght/Over wei ght Sect or Agai nst Benchmar k St r at egy Benchmar k Consumer Discretionary 6.4 % 10.2 % Consumer Staples 1.8 8.3 Energy 17.7 9.6 Financials 24.9 25.4 Health Care 1.1 2.4 Industrials 3.3 7.5 Information Technology 13.9 17.9 Materials 8.6 9.1 Telecom. Services 13.1 6.3 Utilities 9.2 3.3 5.9 6.8 -0.5 -4.0 -4.2 -1.3 -0.5 8.1 -6.5 -3.8 -10 -5 0 5 10 36 As of June 30, 2014 GMO 2014 Quarterly Strategy Attribution Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. GMO Emerging Markets Strategy Inception: 12/31/93; Benchmark: S&P/IFCI Composite Index The Emerging Markets Strategy jumped 8.1% net of fees in the second quarter, outperforming the 7.5% rise in the S&P/IFCI Composite by 0.6%. Overall, country-sector allocation gained 0.4% and stock selection added 0.2%.
Emerging markets went on a bull run in the second quarter. Investor sentiment was boosted by the low valuations, continuing recovery in the U.S., reduced political uncertainty in Ukraine, and an overwhelming mandate for the winning party in Indian elections. Also helping were reports in June of Chinese manufacturing rising at the fastest pace in seven months and a robust expansion in Taiwans factory output. Country returns varied over the quarter, ranging from a 15.1% jump in Turkey to a 10.8% drop in Greece. Sector returns were all positive and more clustered, varying from an 11.2% leap in IT to a more modest return of +3.8% for Materials.
Investor sentiment in Brazil improved with continuing drops in the governments approval rating. Elections are due in October of 2014 and speculation of a change in leadership lifted the market as the current government is seen as prone to micro-managing the economy. Investors expect the opposition to be less inclined to intervene in state-run companies and more focused on reining in inflation. Our overweight in Brazilian Utilities contributed to performance.
The Indian stock market soared after national elections delivered a much stronger mandate than expected. The winning party singlehandedly won a majority of seats, a feat unattained in the last 30 years. Narendra Modi, the newly elected prime minister, is expected to quickly take concrete steps to boost economic growth. Our underweight in Indian Energy and Industrials hurt performance.
The Russian stock market continued its run on the back of easing tensions with Ukraine. Russian president Putin asked lawmakers to revoke his authority to use force in Ukraine - a conciliatory gesture after his meeting with the Ukrainian president. Also helping the market was a jump in oil prices amid turmoil in Iraq and Syria. A $400 billion contract awarded to energy exporter OAO Gazprom to supply fuel to China over 30 years also brought some cheer. Our overweight in Russian Energy boosted performance.
Taiwanese stocks were buoyed by rising optimism for the U.S. and Taiwan economies. Taiwans industrial output rose 5.2% from a year earlier in May, exceeding expectations. The central bank maintained interest rates at 1.875%. Our overweight in Taiwan IT added to performance.
The stock market in Turkey rebounded after the ruling party won local elections. Investors read that as a sign that the political crisis that began last December was coming to an end. The central bank unexpectedly cut its repurchase rate to 9.5% from 10% and floated the possibility of further rate cuts. Toward the end of the quarter, the stock market gave back some of its gains on political tension in Iraq, a key trading partner, and on rising oil prices, a driver of its worrisome current account deficit. Our overweight in Turkish Financials helped performance.
Stock selection was additive to performance with particularly strong selection in China Financials and India Financials. 37 As of June 30, 2014 GMO 2014 GMO Emerging Domestic Opportunities Strategy Inception: 3/31/11 Performance Net of Fees 1 Top Ten Holdings 2,6
Risk Profile Since 3/31/11 4
GICS Sectors 1 Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. 2 Portfolio holdings are percent of equity. They are subject to change and should not be considered a recommendation to buy individual securities. 3 The Emerging Domestic Opportunities Strategy does not have a benchmark. The Strategy has been compared to the MSCI Emerging Markets Index in an effort to compare and contrast the Strategy versus a broad emerging markets index. The MSCI Emerging Markets Index (MSCI Standard Index Series, net of withholding tax) is an independently maintained and widely published index comprised of global emerging markets large and mid capitalization stocks. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder. 4 Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R 2 is a measure of how well a portfolio tracks the market; Sharpe Ratio is the return over the risk free rate per unit of risk; Std. Deviation is a measure of the volatility of a portfolio. Risk profile data is net. 5 Weights are based on exposure, which will include the impact from hedges held, if any. 6 The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the Strategy. Sector Weights 6 Region Weights 5,6
Characteristics 6
Tot al Ret ur n (%) Aver age Annual Tot al Retur n (%) 2Q YTD One Five Ten Since 2014 2014 Year Year Year Inception Strategy 5.60 2.94 5.56 N/A N/A 6.01 Benchmark 3 6.60 6.14 14.31 N/A N/A -0.71 Annual Tot al Ret ur n (%) 2011 2012 2013 Strategy -8.99 24.33 3.80 Benchmark -20.06 18.22 -2.60 St r at egy Benchmar k Alpha 6.54 0.00 Beta 0.76 1.00 R 2 0.83 1.00 Sharpe Ratio 0.38 -0.04 Std. Deviation 15.49 18.63 Colgate-Palmolive Co. 3.6% HDFC Bank Ltd. 2.7% Nestle S.A. 2.5% Yum! Brands Inc. 2.5% Lupin Ltd. 2.3% Abbott Laboratories 2.2% Copa Holdings S.A. (Cl A) 2.1% Grupo Financiero Banorte 1.9% Unilever PLC 1.8% British American Tobacco 1.8% Total 23.4% St r at egy Benchmar k Price/Earnings - Hist 1 Yr Wtd Med 19.4 x 16.2 x Price/Cash Flow - Hist 1 Yr Wtd Med 16.6 x 9.7 x Price/Book - Hist 1 Yr Wtd Avg 2.8 x 1.5 x Return on Equity - Hist 1 Yr Avg 13.9 % 11.8 % Market Cap - Weighted Median $Bil $3.6 $9.0 Number of Equity Holdings 126 835 Dividend Yield - Hist 1 Yr Wtd Avg 2.4 % 2.7 % Under wei ght/Over wei ght Regi on Agai nst Benchmar k (%) Developed East Asia Europe Latin/South America Mideast/Africa South Asia Cash + Unrealized G/L 23.1 -26.0 -5.4 -4.7 -2.8 14.3 1.6 -40 -20 0 20 40 Under wei ght/Over wei ght Sect or Agai nst Benchmar k St r at egy Benchmar k Consumer Discretionary 13.4 % 9.1 % Consumer Staples 21.3 8.2 Energy 2.2 10.8 Financials 26.1 27.0 Health Care 7.4 1.8 Industrials 9.8 6.5 Information Technology 6.5 17.3 Materials 4.2 8.7 Telecom. Services 5.5 7.0 Utilities 3.7 3.6 0.1 -1.5 -4.5 -10.8 3.3 5.6 -0.9 -8.6 13.1 4.3 -20 -10 0 10 20 38 As of June 30, 2014 GMO 2014 Quarterly Strategy Attribution Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. The Emerging Domestic Opportunities Strategy invests in companies whose prospects are linked to the internal growth of the worlds non-developed markets. The strategy uses fundamental analysis within a structured approach to select countries, sectors, and stocks that we believe are the most likely to benefit from the rising demand for goods and services in emerging markets.
Emerging markets went on a bull run in the second quarter. Investor sentiment was boosted by the low valuations, continuing recovery in the U.S., reduced political uncertainty in Ukraine, and an overwhelming mandate for the winning party in Indian elections. Also helping were reports in June of Chinese manufacturing rising at the fastest pace in seven months and a robust expansion in Taiwans factory output. Country returns varied over the quarter, ranging from a 15.1% jump in Turkey to a 10.8% drop in Greece. Domestic demand driven sector returns were all positive and more clustered, varying from a 10.3% leap in Utilities to a more modest 4.1% for Consumer Staples.
The Emerging Domestic Opportunities Strategy rose 5.6% net of fees in the second quarter.
Investor sentiment in Brazil improved with continuing drops in the governments approval rating. Elections are due in October of 2014 and speculation of a change in leadership lifted the market as the current government is seen as prone to micro-managing the economy. Investors expect the opposition to be less prone to intervene in state-run companies and more focused on reining in inflation. Our exposure to Brazilian Industrials contributed to performance.
The Indian stock market soared after national elections delivered a much stronger mandate than expected. The winning party singlehandedly won a majority of seats, a feat unattained in the last 30 years. Narendra Modi, the newly elected prime minister, is expected to quickly take concrete steps to boost economic growth. Our investments in Indian sectors such as Financials, Health Care, Industrials, and Consumer Discretionary boosted performance.
The stock market in Qatar was hit hard by the turmoil in Iraq. Also having a significant impact were fears that the countrys right to host the 2022 soccer World Cup might be at risk. A FIFA panel is looking into the allegations of corruption behind the awarding of the games. Our holdings in Qatar Financials hurt the portfolio.
Taiwanese stocks were buoyed by rising optimism for the U.S. and Taiwan economies. Taiwans industrial output rose 5.2% from a year earlier in May, exceeding expectations. The central bank maintained interest rates at 1.875%. Our positions in Taiwan Financials added to performance. GMO Emerging Domestic Opportunities Strategy Inception: 3/31/11 39 As of June 30, 2014 GMO 2014 Performance Net of Fees 1
GMO Global Bond Strategy Inception: 12/31/95; Benchmark: J.P. Morgan GBI Global Index 1 Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. Returns for one of the accounts in the composite are based on estimated market values for the period from and including October 2008 through February 2009. 2 The J.P. Morgan GBI Global Index is an independently maintained and widely published index comprised of government bonds of developed countries with maturities of one year or more. 3 Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R 2 is a measure of how well a portfolio tracks the market; Sharpe Ratio is the return over the risk free rate per unit of risk; Std. Deviation is a measure of the volatility of a portfolio. Risk profile data is net. 4 The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the Strategy. 5 Region weights are duration adjusted. 5-Year Risk Profile 3
Currency Weights 4 Region Weights 4,5
Characteristics 4
Tot al Ret ur n (%) Aver age Annual Tot al Retur n (%) 2Q YTD One Five Ten Since 2014 2014 Year Year Year Inception Strategy 3.07 7.33 8.97 9.22 5.20 6.04 Benchmark 2 2.28 5.05 6.50 3.80 4.96 5.24 Annual Tot al Retur n (%) 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Strategy 12.12 -5.84 7.94 2.58 -14.93 20.30 14.14 8.30 6.36 -2.56 Benchmark 10.10 -6.53 5.94 10.81 12.00 1.91 6.42 7.22 1.30 -4.50 St r at egy Benchmar k Alpha 5.19 0.00 Beta 1.06 1.00 R 2 0.86 1.00 Sharpe Ratio 1.41 0.66 Std. Deviation 6.47 5.65 Modified Duration 6.7 Emerging Cntry Debt Exp. 4 % Maturity 5.8 Yrs. Under wei ght/Over wei ght Agai nst Benchmar k (%) Emerging Europe North America Pacific 4.4 -4.5 6.1 -17.7 -20 -10 0 10 20 Under wei ght/Over wei ght Agai nst Benchmar k (%) Euro North America Pacific -9.5 16.2 -6.7 -20 -10 0 10 20 40 As of June 30, 2014 GMO 2014 Quarterly Strategy Attribution Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. The Global Bond Strategy returned +3.1% net of fees during the second quarter, outperforming the J.P. Morgan GBI Global index return of +2.3% by 0.8%. The 16-basis-point fall in the index yield accounted for the bulk of positive index returns.
Against the backdrop of sluggish growth in most developed nations and geopolitical tensions in Iraq and Ukraine/Russia, major country government bond markets rose for a second consecutive quarter. The yield on the J.P. Morgan Global Bond index fell by 16 basis points, ending the quarter at 1.9%. In local currency bond index terms, gains were the highest in Australia (+3.7%) and Sweden (+2.8%) and the lowest in Japan (+0.8%). Australian bonds had their best quarter in two years, as the slowing economy and falling iron ore prices put pressure on the Reserve Bank of Australia to keep rates low. In Sweden, the unemployment rate and Q1 GDP came in weaker than expected and confidence figures were disappointing, pushing yields down during the quarter and supporting the case for a Riksbank cut in July. In other bond markets, the euro area, Canada, U.S., U.K., and Switzerland posted total return gains of +0.9% to +2.3%.
Global yield curves (measured by the difference between 10-year and 2-year swap rates) flattened in Q2, with Australia and the U.K. flattening the most.
In currencies, foreign currencies were mixed against the dollar during the quarter. Canadian dollar led gains, +3.6%; Canada's consumer price index rose by 2% from a year ago, casting doubt on a further, near-term interest-rate cut by the Bank of Canada. Sterling followed, posting +2.6% for the quarter as strong data and hawkish BoE comments boosted the currency. New Zealand dollar gained +0.9% during the quarter; the Reserve Bank hiked policy rates in two 25-basis-point increments, ending the quarter at 3.25% and signaling no intention of slowing pace of future rate hikes. Conversely, Swedish krona was weak, -3.0%, as weak data fueled speculation that the Riksbank will cut its target rate in July.
Apart from the New Zealand policy interest rate hikes, the European Central Bank cut rates by 10 basis points, to 0.15%, a historic low.
Exposures to asset-backed securities held indirectly through GMO Debt Opportunities Fund (DOF) and GMO World Opportunity Overlay Fund (WOOF) contributed positively during the second quarter, leading gains. Exposure to emerging country debt via the GMO Emerging Country Debt Fund also contributed positively, followed by gains provided by developed markets interest-rate positioning. GMO Global Bond Strategy Inception: 12/31/95; Benchmark: J.P. Morgan GBI Global Index 41 As of June 30, 2014 GMO 2014 GMO International Bond Strategy Inception: 12/31/93; Benchmark: J.P. Morgan GBI Global ex U.S. Index Performance Net of Fees 1
1 Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. 2 The J.P. Morgan GBI Global ex U.S. Index is an independently maintained and widely published index comprised of non-U.S. government bonds with maturities of one year or more. 3 Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R 2 is a measure of how well a portfolio tracks the market; Sharpe Ratio is the return over the risk free rate per unit of risk; Std. Deviation is a measure of the volatility of a portfolio. Risk profile data is net. 4 The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the Strategy. 5 Region weights are duration adjusted. 5-Year Risk Profile 3
Currency Weights 4 Region Weights 4,5
Characteristics 4
Tot al Ret ur n (%) Aver age Annual Tot al Retur n (%) 2Q YTD One Five Ten Since 2014 2014 Year Year Year Inception Strategy 3.43 8.80 12.88 9.91 5.92 7.23 Benchmark 2 2.68 6.07 8.92 3.80 5.06 5.72 Annual Tot al Retur n (%) 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Strategy 14.88 -8.08 9.33 3.66 -13.95 20.59 15.18 6.71 6.21 -0.57 Benchmark 12.04 -9.24 6.84 11.30 11.39 3.94 6.78 5.91 0.85 -5.08 St r at egy Benchmar k Alpha 5.89 0.00 Beta 1.06 1.00 R 2 0.89 1.00 Sharpe Ratio 1.20 0.51 Std. Deviation 8.22 7.33 Modified Duration 7.2 Emerging Cntry Debt Exp. 4 % Maturity 6.8 Yrs. Under wei ght/Over wei ght Agai nst Benchmar k (%) Emerging Europe North America Pacific 4.1 -3.6 6.8 -17.6 -20 -10 0 10 20 Under wei ght/Over wei ght Agai nst Benchmar k (%) Euro North America Pacific -10.9 17.1 -6.3 -20 -10 0 10 20 42 As of June 30, 2014 GMO 2014 Quarterly Strategy Attribution Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. The International Bond Strategy returned +3.4% net of fees in the second quarter, outperforming the J.P. Morgan GBI Global ex U.S. index return of +2.7% by 0.8%. The 17-basis-point fall in the index yield accounted for the bulk of positive index returns.
Against the backdrop of sluggish growth in most developed nations and geopolitical tensions in Iraq and Ukraine/Russia, major country government bond markets rose for a second consecutive quarter. The yield on the J.P. Morgan Global Bond index fell by 16 basis points, ending the quarter at 1.9%. In local currency bond index terms, gains were the highest in Australia (+3.7%) and Sweden (+2.8%) and the lowest in Japan (+0.8%). Australian bonds had their best quarter in two years, as the slowing economy and falling iron ore prices put pressure on the Reserve Bank of Australia to keep rates low. In Sweden, the unemployment rate and Q1 GDP came in weaker than expected and confidence figures were disappointing, pushing yields down during the quarter and supporting the case for a Riksbank cut in July. In other bond markets, the euro area, Canada, U.S., U.K., and Switzerland posted total return gains of +0.9% to +2.3%.
Global yield curves (measured by the difference between 10-year and 2-year swap rates) flattened in Q2, with Australia and the U.K. flattening the most.
In currencies, foreign currencies were mixed against the dollar during the quarter. Canadian dollar led gains, +3.6%; Canadas consumer price index rose by 2% from a year ago, casting doubt on a further, near-term interest-rate cut by the Bank of Canada. Sterling followed, posting +2.6% for the quarter as strong data and hawkish BoE comments boosted the currency. New Zealand dollar gained +0.9% during the quarter; the Reserve Bank hiked policy rates in two 25-basis-point increments, ending the quarter at 3.25% and signaling no intention of slowing pace of future rate hikes. Conversely, Swedish krona was weak, -3.0%, as weak data fueled speculation that the Riksbank will cut its target rate in July.
Apart from the New Zealand policy interest rate hikes, the European Central Bank cut rates by 10 basis points, to 0.15%, a historic low.
Exposures to asset-backed securities held indirectly through GMO Debt Opportunities Fund (DOF) and GMO World Opportunity Overlay Fund (WOOF) contributed positively during the second quarter, leading gains. Exposure to emerging country debt via the GMO Emerging Country Debt Fund also contributed positively, followed by gains provided by developed markets interest-rate positioning. GMO International Bond Strategy Inception: 12/31/93; Benchmark: J.P. Morgan GBI Global ex U.S. Index 43 As of June 30, 2014 GMO 2014 GMO Currency Hedged International Bond Strategy Inception: 9/30/94; Benchmark: J.P. Morgan GBI Global ex-Japan ex-U.S. (Hedged) Index Performance Net of Fees 1
1 Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. 2 The J.P. Morgan GBI Global ex Japan ex U.S. (Hedged)+ is an internally maintained benchmark computed by GMO, comprised of (i) the J.P. Morgan GBI Global ex U.S. (Hedged) through 12/31/2003 and (ii) the J.P. Morgan GBI Global ex Japan ex U.S. (Hedged) thereafter. 3 Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R 2 is a measure of how well a portfolio tracks the market; Sharpe Ratio is the return over the risk free rate per unit of risk; Std. Deviation is a measure of the volatility of a portfolio. Risk profile data is net. 4 The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the Strategy. 5 Region weights are duration adjusted. 5-Year Risk Profile 3
Currency Weights 4 Region Weights 4,5
Characteristics 4
Tot al Retur n (%) Aver age Annual Tot al Ret ur n (%) 2Q YTD One Five Ten Since 2014 2014 Year Year Year Inception Strategy 3.00 8.03 8.81 9.88 5.37 7.98 Benchmark 2 2.62 6.12 7.56 5.46 5.38 6.91 Annual Total Ret ur n (%) 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Strategy 8.91 7.25 2.45 -4.00 -13.56 18.81 11.70 7.97 11.34 0.14 Benchmark 6.73 6.54 1.79 3.42 9.22 2.90 3.71 6.10 8.07 0.65 St r at egy Benchmar k Alpha 3.77 0.00 Beta 1.12 1.00 R 2 0.76 1.00 Sharpe Ratio 2.01 1.42 Std. Deviation 4.89 3.79 Modified Duration 6.7 Emerging Cntry Debt Exp. 5 % Maturity 6.8 Yrs. Under wei ght/Over wei ght Agai nst Benchmar k (%) Emerging Europe North America Pacific 4.6 -7.5 9.5 -17.2 -20 -10 0 10 20 Under wei ght/Over wei ght Agai nst Benchmar k (%) Euro North America Pacific -9.0 16.2 -7.2 -20 -10 0 10 20 44 As of June 30, 2014 GMO 2014 Quarterly Strategy Attribution Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. The Currency Hedged International Bond Strategy returned +3.0% net of fees in the second quarter, outperforming the J.P. Morgan GBI Global ex Japan ex U.S. (Hedged) index total return of +2.6% by 0.4%. The yield of the J.P. Morgan GBI Global ex Japan ex U.S. (Hedged) index fell by 26 basis points during the quarter.
Against the backdrop of sluggish growth in most developed nations and geopolitical tensions in Iraq and Ukraine/Russia, major country government bond markets rose for a second consecutive quarter. The yield on the J.P. Morgan Global Bond index fell by 16 basis points, ending the quarter at 1.9%. In local currency bond index terms, gains were the highest in Australia (+3.7%) and Sweden (+2.8%) and the lowest in Japan (+0.8%). Australian bonds had their best quarter in two years, as the slowing economy and falling iron ore prices put pressure on the Reserve Bank of Australia to keep rates low. In Sweden, the unemployment rate and Q1 GDP came in weaker than expected and confidence figures were disappointing, pushing yields down during the quarter and supporting the case for a Riksbank cut in July. In other bond markets, the euro area, Canada, U.S., U.K., and Switzerland posted total return gains of +0.9% to +2.3%.
Global yield curves (measured by the difference between 10-year and 2-year swap rates) flattened in Q2, with Australia and the U.K. flattening the most.
In currencies, foreign currencies were mixed against the dollar during the quarter. Canadian dollar led gains, +3.6%; Canada's consumer price index rose by 2% from a year ago, casting doubt on a further, near-term interest-rate cut by the Bank of Canada. Sterling followed, posting +2.6% for the quarter as strong data and hawkish BoE comments boosted the currency. New Zealand dollar gained +0.9% during the quarter; the Reserve Bank hiked policy rates in two 25-basis-point increments, ending the quarter at 3.25% and signaling no intention of slowing pace of future rate hikes. Conversely, Swedish krona was weak, -3.0%, as weak data fueled speculation that the Riksbank will cut its target rate in July.
Apart from the New Zealand policy interest rate hikes, the European Central Bank cut rates by 10 basis points, to 0.15%, a historic low.
Exposures to asset-backed securities held indirectly through GMO Debt Opportunities Fund (DOF) and GMO World Opportunity Overlay Fund (WOOF) contributed positively during the second quarter, leading gains. Exposure to emerging country debt via the GMO Emerging Country Debt Fund also contributed positively, followed by gains provided by developed markets interest-rate positioning. GMO Currency Hedged International Bond Strategy Inception: 9/30/94; Benchmark: J.P. Morgan GBI Global ex-Japan ex-U.S. (Hedged) Index 45 As of June 30, 2014 GMO 2014 GMO Core Plus Bond Strategy Inception: 4/30/97; Benchmark: Barclays U.S. Aggregate Index Performance Net of Fees 1
5-Year Risk Profile 3
1 Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. 2 The Barclays U.S. Aggregate Index is an independently maintained and widely published index comprised of U.S. fixed rate debt issues having a maturity of at least one year and rated investment grade or higher. 3 Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R 2 is a measure of how well a portfolio tracks the market; Sharpe Ratio is the return over the risk free rate per unit of risk; Std. Deviation is a measure of the volatility of a portfolio. Risk profile data is net. 4 The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the Strategy. 5 Region weights are duration adjusted. Currency Weights 4 Region Weights 4,5
Characteristics 4
Tot al Ret ur n (%) Aver age Annual Tot al Retur n (%) 2Q YTD One Five Ten Since 2014 2014 Year Year Year Inception Strategy 2.59 5.74 6.44 9.90 5.06 6.10 Benchmark 2 2.04 3.93 4.37 4.85 4.93 5.81 Annual Tot al Retur n (%) 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Strategy 6.59 3.95 5.76 -1.01 -18.00 20.90 13.24 9.89 9.07 0.07 Benchmark 4.34 2.43 4.33 6.97 5.24 5.93 6.54 7.84 4.22 -2.03 St r at egy Benchmar k Alpha 3.29 0.00 Beta 1.37 1.00 R 2 0.79 1.00 Sharpe Ratio 2.25 1.69 Std. Deviation 4.36 2.83 Modified Duration 5.1 Emerging Cntry Debt Exp. 5 % Maturity 4.5 Yrs. Under wei ght/Over wei ght Agai nst Benchmar k (%) Emerging Europe North America Pacific 4.7 -7.8 8.7 -17.1 -20 -10 0 10 20 Under wei ght/Over wei ght Agai nst Benchmar k (%) Euro North America Pacific -10.0 17.2 -7.3 -20 -10 0 10 20 46 As of June 30, 2014 GMO 2014 Quarterly Strategy Attribution Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. GMO Core Plus Bond Strategy Inception: 4/30/97; Benchmark: Barclays U.S. Aggregate Index The Core Plus Bond Strategy returned +2.6% net of fees during the second quarter, outperforming the +2.0% return of its benchmark, the Barclays U.S. Aggregate index, by 0.5%. Tightening sector spreads and falling yields on the long end of the U.S. Treasury curve contributed positively to index performance.
The overall option-adjusted spread of the Barclays U.S. Aggregate index tightened by 6 basis points during the quarter, with spreads tightening by as much as 21 basis points (CMBS) and by as little as 1 basis point (double-A credit).
U.S. interest rates were mixed, and the U.S. Treasury yield curve flattened during the quarter: the 10-year U.S. Treasury yield fell by 21 basis points to end the quarter at 2.5%, while 2-year yields rose by 3 basis points to end the quarter at 0.5%.
Exposures to asset-backed securities held indirectly through GMO Debt Opportunities Fund (DOF) and GMO World Opportunity Overlay Fund (WOOF) contributed positively during the second quarter, leading gains. Exposure to emerging country debt via the GMO Emerging Country Debt Fund also contributed positively, followed by gains provided by developed markets interest-rate positioning and developed markets currency selection 47 As of June 30, 2014 GMO 2014 GMO Debt Opportunities Strategy Inception: 10/31/11; Benchmark: J.P. Morgan U.S. 3 Month Cash Index Performance Net of Fees 1
Risk Profile Since 10/31/11 3
1 Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. 2 The J.P. Morgan U.S. 3 Month Cash Index is an independently maintained and widely published index comprised of three month U.S. dollar Euro-deposits. The duration of the Index is generally 90 days. 3 Std. Deviation is a measure of the volatility of a portfolios return. Sharpe Ratio is the return over the risk free rate per unit of risk. Drawdown is the largest negative cumulative portfolio return from peak to trough. Risk profile data is net. 4 The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the Strategy. Country Weights 4
Tot al Ret ur n (%) Aver age Annual Tot al Retur n (%) 2Q YTD One Five Ten Since 2014 2014 Year Year Year Inception Strategy 1.70 3.19 6.08 N/A N/A 7.84 Benchmark 2 0.08 0.17 0.36 N/A N/A 0.57 Annual Tot al Ret ur n (%) 2011 2012 2013 Strategy 0.16 11.90 5.76 Benchmark 0.12 0.82 0.40 St r at egy Std. Deviation 1.85 Sharpe Ratio 4.22 Drawdown (5/31/13-6/30/13) -1.23 Under wei ght /Over wei ght Agai nst Benchmar k (%) Australia Ireland Other United Kingdom United States 0.4 0.3 0.4 0.8 -2.0 -4 -2 0 2 4 48 As of June 30, 2014 GMO 2014 Quarterly Strategy Attribution Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. The Debt Opportunities Strategy returned +1.7% net of fees, outperforming the return of the J.P. Morgan U.S. 3 Month Cash index by 1.6% for the second quarter.
During the second quarter, asset-backed spreads were flat to tighter across sectors. According to J.P. Morgan, credit card spreads for five-year triple-B floaters decreased from 90 basis points to 71 basis points, auto loan spreads for three-year triple-B bonds were unchanged at 120 basis points, and private student loan spreads for seven-year triple-A bonds decreased from 115 basis points to 100 basis points. Prices of the ABX subprime triple-A indexes were flat to up 4% with the lower collateral quality 2007 vintages performing the best. GMO Debt Opportunities Strategy Inception: 10/31/11; Benchmark: J.P. Morgan U.S. 3 Month Cash Index 49 As of June 30, 2014 GMO 2014 1 Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. 2 The J.P. Morgan U.S. 3 Month Cash Index is an independently maintained and widely published index comprised of three month U.S. dollar Euro-deposits. The duration of the Index is generally 90 days. 3 Std. Deviation is a measure of the volatility of a portfolios return. Sharpe Ratio is the return over the risk free rate per unit of risk. Drawdown is the largest negative cumulative portfolio return from peak to trough. Risk profile data is net. 4 The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the Strategy. Performance Net of Fees 1 5-Year Risk Profile 3
Performance Attribution 4 Country Weights 4
GMO Fixed Income Hedge Strategy Inception: 8/31/05; Benchmark: J.P. Morgan U.S. 3 Month Cash Index Tot al Ret ur n (%) Aver age Annual Tot al Ret ur n (%) 2Q YTD One Five Ten Since 2014 2014 Year Year Year Inception Strategy 1.40 5.99 2.51 8.96 N/A -0.34 Benchmark 2 0.08 0.17 0.36 0.53 N/A 2.26 Annual Tot al Ret ur n (%) 2005 2006 2007 2008 2009 2010 2011 2012 2013 Strategy 1.45 -4.61 -23.39 -25.45 21.63 11.03 15.85 10.07 -3.79 Benchmark 1.32 5.25 5.70 4.12 1.45 0.45 0.44 0.82 0.40 St r at egy Std. Deviation 7.87 Sharpe Ratio 1.13 Drawdown (4/30/13-8/31/13) -12.05 Net Cont r i but i on (%) Cross-Market Tactical Duration Overlay Yield Curve Swaption Volatility STRIPS vs. LIBOR Other Opportunistic Cash Mgmt/ABS/Fees/Other 2.9 0.1 0.0 -0.3 0.0 0.0 -1.3 -4 -2 0 2 4 Net Wei ght (%) Asia/Pacific North America Europe -160.1 72.8 34.5 -200 -100 0 100 200 50 As of June 30, 2014 GMO 2014 Quarterly Strategy Attribution Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. The Fixed Income Hedge Strategy returned +1.4% net of fees in the second quarter of 2014, outperforming its benchmark, the J.P. Morgan U.S. 3 Month Cash index, by 1.3%. Cross-market strategies drove gains during the quarter, followed by a small contribution from tactical duration position. Mortgage spreads and swaption volatility detracted.
Against the backdrop of sluggish growth in most developed nations and geopolitical tensions in Iraq and Ukraine/Russia, major country government bond markets rose for a second consecutive quarter. The yield on the J.P. Morgan Global Bond index fell by 16 basis points, ending the quarter at 1.9%. In local currency bond index terms, gains were the highest in Australia (+3.7%) and Sweden (+2.8%) and the lowest in Japan (+0.8%). Australian bonds had their best quarter in two years, as the slowing economy and falling iron-ore prices put pressure on the Reserve Bank of Australia to keep rates low. In Sweden, the unemployment rate and Q1 GDP came in weaker than expected and confidence figures were disappointing, pushing yields down during the quarter and supporting the case for a Riksbank cut in July. In other bond markets, the euro area, Canada, U.S., U.K., and Switzerland posted total return gains of +0.9% to +2.3%.
Global yield curves (measured by the difference between 10-year and 2-year swap rates) flattened in Q2, with Australia and the U.K. flattening the most.
In policy actions, the European Central Bank cut rates by 10 basis points, to 0.15%, a historic low.
The cross-market strategy posted gains due to long positions in the U.S., Sweden, and Australia. Short positions in Japan, Switzerland, and the U.K. detracted, but were unable to fully offset gains. The slope strategy benefited from flattening euro and Swiss curves, but this was offset by losses from the British pound curve. Opportunistic strategies added value given a steeper forward yield curve in the U.S. Tactical Duration positioning added value; the strategy was long U.S. duration as U.S. Treasuries rallied.
A mortgage spread widening position detracted as spreads tightened. The swaption volatility strategy also detracted as both implied and realized volatility continued to remain low in the U.S. interest rate market.
A currency strategy ramped up at the end of the quarter, where a euro short posted a small loss. GMO Fixed Income Hedge Strategy Inception: 8/31/05; Benchmark: J.P. Morgan U.S. 3 Month Cash Index 51 As of June 30, 2014 GMO 2014 GMO Mean Reversion Strategy Inception: 2/28/02; Benchmark: Citigroup 3-Month T-Bill Index 1 Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. 2 The Citigroup 3-Month Treasury Bill Index is an independently maintained and widely published index comprised of short-term U.S. Treasury bills. 3 Std. Deviation is a measure of the volatility of a portfolios return. Sharpe Ratio is the return over the risk free rate per unit of risk. Drawdown is the largest negative cumulative portfolio return from peak to trough. Risk profile data is net. 4 The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the Strategy. 5 Displayed in local 10-year equivalents. Performance Net of Fees 1 5-Year Risk Profile 3
Fixed Income & Inflation Exposure 4,5
Currency Exposure 4 Other Exposure 4
Tot al Ret ur n (%) Aver age Annual Tot al Ret ur n (%) 2Q YTD One Five Ten Since 2014 2014 Year Year Year Inception Strategy -0.84 0.06 -4.29 0.30 4.49 7.17 Benchmark 2 0.01 0.02 0.04 0.08 1.54 1.49 Annual Tot al Ret ur n (%) 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Strategy 11.42 6.97 5.63 18.63 18.43 -13.43 -8.61 6.77 5.98 -0.62 Benchmark 1.24 3.00 4.76 4.74 1.80 0.16 0.13 0.08 0.07 0.05 Equity Exposure 4
St r at egy Std. Deviation 6.28 Sharpe Ratio 0.03 Drawdown (1/31/10-12/31/10) -10.68 Posi t i on Absol ut e % Euro Indian Rupee Emerging Currencies Commodity Currencies Israeli New Shekel Asia Currency Basket Swiss Francs 16.6 12.4 4.8 -4.8 -9.5 -10.0 -14.3 -20 -10 0 10 20 Posi t i on Absol ut e % Credit Opportunies Fund 5.0 -6 -3 0 3 6 Posi t i on Absol ut e % AUD 10 Yr. Bonds Kiwi 10 Yr. Bonds U.S. 10 Yr. Bonds Canadian Rates UK 10 Yr. Bonds German Bunds Japanese Interest Rates 30.0 16.8 15.4 -5.0 -5.0 -30.6 -48.5 -80 -40 0 40 80 Posi t i on Absol ut e % U.S. Equities Financials S&P 500 87.4 15.5 -96.0 -200 -100 0 100 200 52 As of June 30, 2014 GMO 2014 Quarterly Strategy Attribution Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. Mean Reversion Strategy delivered a net return of -0.8% during the second quarter of 2014. Both stocks and bonds delivered positive performance during the quarter with the S&P 500 up +5.2%, MSCI EAFE up +4.1%, MSCI Emerging Markets up +6.6%, and Barclays U.S. Aggregate up +2.0%.
The most significant performance driver for the quarter was the Quality vs. S&P 500 spread trade, which contributed -1.0% as high quality stocks underperformed the broader U.S. equity market during the quarter. This negative performance was partially offset by the anti-China trade, which contributed +0.5% as China underperformed the broader Emerging Markets universe during the quarter.
Our bond positions added value during the quarter. It was a good quarter for bonds globally, with 10-year U.S. Treasury yields falling 0.2% and German Bunds yields down 0.3%. Australia and New Zealand bonds experienced a strong rally with yields on their 10-year bonds down 0.5% and 0.2%, respectively. Our long Australia and New Zealand trade added about +0.5% during the quarter. JGBs trailed in the rally with only a marginal drop in yields; our short position relative to global bonds added +0.2%. The short German Bunds position detracted from performance by -0.2%; we increased this position during the month.
The currency positions had a negative impact on performance during the quarter. The rupee was up during the quarter, but did not keep up with Asian currencies; that trade detracted 0.2%. The Israeli shekel strengthened during the quarter; our short detracted 0.2% from performance. The Australian, New Zealand, and Canadian dollars all strengthened; our commodity currency short position detracted 0.1%. Both the Chinese yuan short and the euro/Swiss franc trade detracted marginally from performance during the quarter.
Credit Opportunities was up +3.1% during the second quarter, contributing positively to overall performance.
We continue to be concerned about the credit and fixed asset bubble in China, however China is not the only emerging market that is overextended on credit. Further, Chinese stocks are not particularly expensive; in fact, many stocks that we might short for the anti- China trade currently appear cheap based on traditional valuation measures. For these reasons, we closed out our anti-China equity trade and our short position in the Chinese yuan during the quarter. Both of those positions have contributed positively to strategy performance year to date with the anti-China trade adding +0.7% and the Chinese yuan short adding +0.5%. GMO Mean Reversion Strategy Inception: 2/28/02; Benchmark: Citigroup 3-Month T-Bill Index 53 As of June 30, 2014 GMO 2014 GMO Systematic Global Macro Strategy Inception: 3/31/02; Benchmark: Citigroup 3-Month T-Bill Index 1 Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. 2 The Citigroup 3-Month Treasury Bill Index is an independently maintained and widely published index comprised of short-term U.S. Treasury bills. 3 Std. Deviation is a measure of the volatility of a portfolios return. Sharpe Ratio is the return over the risk free rate per unit of risk. Drawdown is the largest negative cumulative portfolio return from peak to trough. Risk profile data is net. 4 The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the Strategy. Performance Net of Fees 1 5-Year Risk Profile 3
Bond Market Selection 4
Currency Selection 4
Commodity Markets 4
Equity Market Selection 4
Tot al Ret ur n (%) Aver age Annual Tot al Ret ur n (%) 2Q YTD One Five Ten Since 2014 2014 Year Year Year Inception Strategy -0.67 1.41 4.79 7.11 6.71 7.34 Benchmark 2 0.01 0.02 0.04 0.08 1.54 1.49 Annual Tot al Ret ur n (%) 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Strategy 1.33 4.63 8.39 15.06 -3.88 15.28 10.37 5.79 0.73 9.58 Benchmark 1.24 3.00 4.76 4.74 1.80 0.16 0.13 0.08 0.07 0.05 * The U.S. Dollar exposure is a balancing item for foreign exchange positions. It should not be included in gross exposure calculations. ** The Cash exposure is a balancing item for all other positions (including foreign exchange, but excluding U.S. Dollar). It should not be included in gross exposure calculations. St r at egy Std. Deviation 6.65 Sharpe Ratio 1.06 Drawdown (5/31/10-7/31/10) -5.61 Count r y Net Wei ght (%) United Kingdom Italy MSCI Emerging Taiwan Netherlands France Singapore VIX Australia Japan Net Equity Markets 24.5 20.0 19.5 15.0 11.0 5.0 5.0 -2.3 -2.5 -38.0 57.3 -80 -40 0 40 80 Count r y Net Wei ght (%) United States Asset Backed Japan Net Bond Markets 30.0 0.9 -50.0 -19.1 -60 -30 0 30 60 Cur r ency Net Wei ght (%) U.S. Dollar * Swedish Krona Canadian Dollar Net Cash ** 20.0 -5.0 -15.0 -36.9 -60 -30 0 30 60 Commodi t y Net Wei ght (%) Soybeans Natural Gas Cattle Cocoa Cotton Crude Oil Heating Oil Corn Wheat Hogs Soy Oil Copper Gasoline Gold Net Commodity 13.3 5.0 3.3 2.5 2.5 0.8 -0.3 -1.5 -1.5 -2.0 -2.5 -5.0 -5.8 -10.0 -1.3 -20 -10 0 10 20 54 As of June 30, 2014 GMO 2014 Quarterly Strategy Attribution Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. The Systematic Global Macro Strategy returned -0.7% net of fees over the June quarter on negative market selection.
Commodity market selection cost 1.4%, due mostly to a long position in soybeans, which fell 8.6% in the month of June. Long positions in natural gas and cotton also lost value. Equity market selection cost 1.2% as our largest short position in Japan advanced 2.3%, outperforming a large long position in Italy. Currency selection cost 1.1% as the Canadian and Australian dollars, held short, advanced against the greenback.
Asset allocation was positive. With global equity markets advancing 4.9% (as measured by the MSCI World Net Returns Index in USD), our net long equity markets allocation contributed 2.3% to portfolio return. Other positions that added value included short positions in Japanese bonds and VIX futures.
The strategy holds a net long exposure to equity markets, favoring attractively priced European markets and emerging markets. We hold a meaningful net short bond allocation, positioned to profit from U.S. bonds outperforming Japanese bonds. The strategy is long the U.S. dollar against the Canadian dollar. In commodities we hold long positions in agriculture, offset by short positions in metals. GMO Systematic Global Macro Strategy Inception: 3/31/02; Benchmark: Citigroup 3-Month T-Bill Index 55 As of June 30, 2014 GMO 2014 GMO Tactical Opportunities Strategy Inception: 9/30/04; Benchmark: Citigroup 3-Month T-Bill Index 1 Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. 2 The Citigroup 3-Month Treasury Bill Index is an independently maintained and widely published index comprised of short-term U.S. Treasury bills. 3 The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the Strategy. Exposure information is not normalized and shown as a percent of total net assets. 4 Std. Deviation is a measure of the volatility of a portfolios return. Sharpe Ratio is the return over the risk free rate per unit of risk. Drawdown is the largest negative cumulative portfolio return from peak to trough. Risk profile data is net. Performance Net of Fees 1
5-Year Risk Profile 4 Characteristics 3
Sector Exposure 3 Region Weights 3
GICS Sectors Tot al Retur n (%) Aver age Annual Total Retur n (%) 2Q YTD One Five Ten Since 2014 2014 Year Year Year Inception Strategy -5.01 -7.51 -14.93 -12.25 N/A -7.22 Benchmark 2 0.01 0.02 0.04 0.08 N/A 1.55 Annual Tot al Retur n (%) 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Strategy -7.57 -13.24 -1.65 17.87 36.52 -41.60 -25.31 27.51 -18.36 -9.64 Benchmark 0.44 3.00 4.76 4.74 1.80 0.16 0.13 0.08 0.07 0.05 Sect or Net Wei ght Long Shor t Consumer Discretionary 8.0 % 27.5 % Consumer Staples 31.3 1.6 Energy 7.2 20.1 Financials 0.0 14.3 Health Care 32.2 14.2 Industrials 9.1 14.2 Information Technology 46.0 17.5 Materials 1.4 12.5 Telecom. Services 1.6 4.6 Utilities 0.0 13.1 -13.1 -3.0 -11.1 28.5 -5.1 18.0 -14.3 -12.9 29.7 -19.5 -40 -20 0 20 40 St r at egy Std. Deviation 18.25 Sharpe Ratio -0.68 Drawdown (6/30/09-6/30/14) -47.96 Long Shor t P/E - Ex Neg Earn Hist 1 Yr Wtd Med 19.6 x 25.1 x % Negative Earnings 1.2 % 38.1 % Price/Book - Hist 1 Yr Wtd Avg 3.9 x 2.8 x Return on Equity - Hist 1 Yr Med 20.1 % 8.4 % Market Cap - Weighted Median $Bil $132.9 $13.0 Debt/Equity Wtd Med 0.5 x 1.5 x % Long/Short 137 % 140 % Dividend Yield - Hist 1 Yr Wtd Avg 2.3 % 1.5 % Regi on Net Wei ght U.S. Non-U.S. 14.5 -17.2 -20 -10 0 10 20 56 As of June 30, 2014 GMO 2014 Quarterly Strategy Attribution Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. The Tactical Opportunities Strategy lost 5.0% net of fees in the second quarter of 2014. The positive contributions from the long portfolio failed to offset the negative impacts of the short portfolio in the second quarter.
Quality stocks underperformed the broad market (S&P 500) in the second quarter while the market favored companies with higher fundamental volatility and price volatility over companies with low fundamental volatility and price volatility.
Large cap stocks lost to the broad market both within quality and the larger universe yet outperformed small cap stocks. The components of quality - low leverage, stable and high profits - had mixed results for the quarter. Low leverage and high profitability were a push with the broad market, while low profit volatility decidedly underperformed.
In the long portfolio, U.S. high quality stocks underperformed non-U.S. high quality stocks. The top contributors in the long portfolio were Health Care, Consumer Staples, and Information Technology. The top individual stocks contributing to returns were Apple, AstraZeneca, and Cisco Systems.
The only detracting sector for the quarter was Consumer Discretionary, which posted modest negative returns. Oracle, Express Scripts, and IBM detracted the most in their respective sectors.
The opposite was seen in the short portfolio, with all sectors detracting from performance. Short exposure within Energy followed by Consumer Discretionary caused the majority of the negative returns for the quarter.
The strategys average net exposure for the quarter remained neutral. GMO Tactical Opportunities Strategy Inception: 9/30/04; Benchmark: Citigroup 3-Month T-Bill Index 57 As of June 30, 2014 GMO 2014 GMO Total Equities Strategy Inception: 9/30/00; Benchmark: Citigroup 3-Month T-Bill Index 1 Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. 2 The Citigroup 3-Month Treasury Bill Index is an independently maintained and widely published index comprised of short-term U.S. Treasury bills. 3 The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the Strategy. 4 Total exposure to downside equity moves, excluding effect of hedges and short positions, as a percent of total net assets. Performance Net of Fees 1
Exposure 3,4
Tot al Retur n (%) Aver age Annual Total Retur n (%) 2Q YTD One Five Ten Since 2014 2014 Year Year Year Inception Strategy 2.53 3.68 17.12 6.87 3.54 6.59 Benchmark 2 0.01 0.02 0.04 0.08 1.54 1.77 Annual Total Ret ur n (%) 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Strategy 1.07 3.56 -1.90 -5.37 14.26 -7.47 3.51 0.40 8.64 17.49 Benchmark 1.24 3.00 4.76 4.74 1.80 0.16 0.13 0.08 0.07 0.05 By St r at egy (%) Equities Merger Arbitrage Volatility Other Total 41.8 37.4 20.8 0.0 100.0 By Regi on (%) U.S. Non-U.S. Total 52.5 47.5 100.0 58 As of June 30, 2014 GMO 2014 Quarterly Strategy Attribution Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends and other income. GMO Total Equities Strategy Inception: 9/30/00; Benchmark: Citigroup 3-Month T-Bill Index Global equities posted strong gains during the second quarter, as the potent combination of improving economic growth and continued stimulus from central banks around the globe gave investors cause for optimism. While geopolitical concerns remained a prominent story, headlined this quarter by sectarian violence in Iraq, they weren't enough to deter investor appetite for equity risk. The MSCI ACWI index quarterly return of +5.0% was driven by broad gains across the global equity market. Japanese and emerging market equities led the pack, with the MSCI Japan index gaining 6.7% and the MSCI Emerging Markets index adding 6.6% during the quarter. U.K. equities were similarly strong, with the MSCI U.K. index returning +6.1%. The U.S. market, as measured by the S&P 500, returned +5.2%, while the MSCI Europe index gained 3.3%.
The Total Equities Strategy returned +2.5% net of fees for the period, with the majority of the positive absolute result driven by exposure to Equities and Volatility.
Our equities strategies posted a +4.9% return for the period, a result that modestly trailed the MSCI ACWI index.
Our volatility strategies posted a +3.3% return for the quarter while merger arbitrage delivered a +0.7% return for the period. 59 Full Name Description Barclays U.S. Aggregate Index The Barclays U.S. Aggregate Index is an independently maintained and widely published index comprised of U.S. fixed rate debt issues having a maturity of at least one year and rated investment grade or higher. Citigroup 3-Month T-Bill Index The Citigroup 3-Month Treasury Bill Index is an independently maintained and widely published index comprised of short-term U.S. Treasury bills. CPI Index The CPI (Consumer Price Index) for All Urban Consumers US All Items is published monthly by the U.S. government as an indicator of changes in price levels (or inflation) paid by urban consumers for a representative basket of goods and services. GMO Blended Global All Country Equity Allocation Index The blended Global All Country Equity Allocation Composite benchmark is comprised of a weighted average of account benchmarks; many of the account benchmarks consist of MSCI ACWI (All Country World Index) (MSCI standard Index Series, net of withholding tax) or some like proxy for each market exposure they have. For each underlying account benchmark, the weighting of each market index will vary slightly. The index is internally blended by GMO and maintained on a monthly basis. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder. GMO Blended Global Asset Allocation Index The blended Global Asset Allocation Composite benchmark is comprised of a weighted average of account benchmarks; many of the account benchmarks consist of S&P 500, MSCI ACWI (MSCI Standard Index Series, net of withholding tax) and Barclays Aggregate or some like proxy for each market exposure they have. For each underlying account benchmark, the weighting of each market index will vary slightly. The index is internally blended by GMO and maintained on a monthly basis. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder. GMO Blended Global Developed Equity Allocation Index The blended Global Developed Equity Allocation Composite benchmark is comprised of a weighted average of account benchmarks; many of the account benchmarks consist of MSCI World (MSCI Standard Index Series, net of withholding tax) or some like proxy for each market exposure they have. For each underlying account benchmark, the weighting of each market index will vary slightly. The index is internally blended by GMO and maintained on a monthly basis. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder. GMO Blended International All Country Equity Allocation Index The blended International All Country Equity Allocation Composite benchmark is comprised of a weighted average of account benchmarks; many of the account benchmarks consist of MSCI ACWI (All Country World) ex-U.S. Index (MSCI Standard Index Series, net of withholding tax) or some like proxy for each market exposure they have. For each underlying account benchmark, the weighting of each market index will vary slightly. The index is internally blended by GMO and maintained on a monthly basis. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder. GMO Blended International Developed Equity Allocation Index The blended International Developed Equity Allocation Composite benchmark is comprised of a weighted average of account benchmarks; many of the account benchmarks consist of MSCI EAFE (MSCI Standard Index Series, net of withholding tax) or some like proxy for each market exposure they have. For each underlying account benchmark, the weighting of each market index will vary slightly. The index is internally blended by GMO and maintained on a monthly basis. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder. GMO Blended Real Return Global Balanced Asset Allocation Index The blended Real Return Global Balanced Asset Allocation Composite benchmark is comprised of a weighted average of account benchmarks; many of the account benchmarks consist of MSCI World (MSCI Standard Index Series, net of withholding tax), Barclays Aggregate, and Citigroup 3-Month T-Bill or some like proxy for each market exposure they have. For each underlying account benchmark, the weighting of each market index will vary slightly. The index is internally blended by GMO and maintained on a monthly basis. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder. GMO Blended U.S. Equity Allocation Index The blended U.S. Equity Allocation Composite benchmark is comprised of a weighted average of account benchmarks; many of the account benchmarks consist of S&P 500, Russell 3000 or some like proxy for each market exposure they have. For each underlying account benchmark, the weighting of each market index will vary slightly. The index is internally blended by GMO and maintained on a monthly basis. Russell Investments is the source and owner of the Russell index data contained or reflected in this material and all trademarks and copyrights related thereto. The presentation may contain confidential information and unauthorized use, disclosure, copying, dissemination or redistribution is strictly prohibited. This is GMOs presentation of the data. FCR is not responsible for the formatting or configuration of this material or for any inaccuracy in GMOs presentation thereof. GMO Tax-Managed Global Balanced Index The Tax-Managed Global Balanced Index is an internally computed benchmark comprised of (i) 60% MSCI ACWI (All Country World Index) (MSCI standard Index Series, net of withholding tax) and (ii) 40% Barclays Muni 7 Year (6-8) Index. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder. J.P. Morgan GBI Global The J.P. Morgan GBI Global Index is an independently maintained and widely published index comprised of government bonds of developed countries with maturities of one year or more. J.P. Morgan GBI Global ex Japan ex U.S. (Hedged) + The J.P. Morgan GBI Global ex-Japan ex-U.S. (Hedged)+ Index is an internally maintained benchmark computed by GMO, comprised of (i) the J.P. Morgan GBI Global ex U.S. (Hedged) through 12/31/2003 and (ii) the J.P. Morgan GBI Global ex Japan ex U.S. (Hedged) thereafter. J.P. Morgan GBI Global ex- U.S. Index The J.P. Morgan GBI Global ex-U.S. Index is an independently maintained and widely published index comprised of non-U.S. government bonds with maturities of one year or more. J.P. Morgan U.S. 3 Month Cash Index The J.P. Morgan U.S. 3 Month Cash Index is an independently maintained and widely published index comprised of three month U.S. dollar Euro-deposits. The duration of the Index is generally 90 days. Benchmarks and Indices GMO measures each strategys performance against a specific benchmark or index (each, a Benchmark), although no strategy is managed as an index strategy or index-plus strategy. Actual composition of a strategys portfolio may differ to varying degrees from that of its Benchmark. Indices are not managed and do not pay fees and expenses. One cannot invest directly in an index. In some cases, a strategys Benchmark differs from the broad based index against which performance is shown in the strategys prospectus. GMO may change a strategys benchmark from time to time. 60 Full Name Description MSCI ACWI The MSCI ACWI (All Country World) Index (MSCI Standard Index Series, net of withholding tax) is an independently maintained and widely published index comprised of global developed and emerging markets. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder. MSCI ACWI Commodity Producers The MSCI ACWI (All Country World) Commodity Producers Index (MSCI Standard Index Series, net of withholding tax) is an independently maintained and widely published index comprised of listed large and mid capitalization commodity producers within the global developed and emerging markets. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder. MSCI EAFE Index The MSCI EAFE (Europe, Australasia, and Far East) Index (MSCI Standard Index Series, net of withholding tax) is an independently maintained and widely published index comprised of international large and mid capitalization stocks. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder. MSCI Emerging Markets Index The MSCI Emerging Markets Index (MSCI Standard Index Series, net of withholding tax) is an independently maintained and widely published index comprised of global emerging markets large and mid capitalization stocks. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder. Russell 3000 Index The Russell 3000 Index is an independently maintained and widely published index comprised of the stocks of the 3,000 largest U.S. companies based on total market capitalization. These companies represent approximately 98% of the total market capitalization of the U.S. equity market. Russell Investment Group is the source and owner of the trademarks, service marks and copyrights related to the Russell Indexes. Russell is a trademark of Russell Investment Group. S&P 500 Index The S&P 500 Index is an independently maintained and widely published index comprised of U.S. large capitalization stocks. S&P does not guarantee the accuracy, adequacy, completeness or availability of any data or information and is not responsible for any errors or omissions from the use of such data or information. Reproduction of the data or information in any form is prohibited except with the prior written permission of S&P or its third party licensors. S&P Developed ex-U.S. Small Cap Index The S&P Developed ex-U.S. Small Cap Index is an independently maintained and widely published index comprised of the small capitalization stock component of the S&P Broad Market Index (BMI). The BMI includes listed shares of companies from developed and emerging countries with a total available market capitalization (float) of at least the local equivalent of $100 million USD. The S&P Developed ex-U. S. Small Cap Index represents the bottom 15% of available market capitalization (float) of the BMI in each country. S&P/IFCI Composite Index The S&P/IFCI Composite Index is an independently maintained and widely published index comprised of emerging markets stocks. S&P does not guarantee the accuracy, adequacy, completeness or availability of any data or information and is not responsible for any errors or omissions from the use of such data or information. Reproduction of the data or information in any form is prohibited except with the prior written permission of S&P or its third party licensors. 61